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ABSTRACT
SUPRAMOLECULAR STRATEGIES FOR THE GENERATION OF
NANOPARTICLE ASSEMBLIES AND BIOMOLECULAR THIN FILMS
FEBRUARY 2016
BRADLEY P. DUNCAN, H.A.B., SAINT ANSELM COLLEGE
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Vincent M. Rotello
The conceptual framework of supramolecular chemistry elucidates a powerful set
of strategies for chemists to generate functional nanomaterials based on intermolecular
forces.

My research focused on tuning the molecular interactions of nanoscale

components to create larger structures with enhanced properties. In one approach, I
developed and optimized an additive-free, nanoimprint lithography-based methodology
to generate stable thin films from a variety of proteins. The generalized process retains
intrinsic properties of the protein as demonstrated by selective cellular adhesion. The
heat and pressure of the nanoimprinting process induces slight structural reorganization
of the peptide side chains to yield highly stable films held together by inter-protein
hydrophobic forces. The selective cell adhesion shown by our initial model proteins was
further harnessed using inkjet printing to control the micropatterning of biomaterial
substrates in a highly modular fashion.

The protein-based ‘ink’ deposition when

combined with the nanoimprint lithography stabilization procedure permits the rapid
creation of patterns and film compositions not achievable using other nanomanufacturing
techniques. My research also demonstrates that the supramolecular interactions that

vii

occur at the surface of nanomaterials can be used to create complexes to interact with the
human olfactory system. Surface functionalized gold nanoparticles serve as selective and
reversible inhibitors for enzymes that upon displacement by analytes in solution generate
a scent-based signal from pro-fragrance molecules. The self-assembly of nanoparticles at
oil/water interfaces led to the development of an alternative method to form nanoparticlepolymer nanocomposites. The assembled composite system, generated by crosslinking
and phase transferring hydrophilic nanoparticles into the hydrophobic oil core, showed
remarkable stability to the phase disrupting influence of ethanol.

This inside-out

Pickering emulsion template later aided in the creation of a multimodal nanoparticle
stabilized capsule platform for the treatment of bacterial biofilms. The amine surface
functionality of the nanoparticles both improved delivery to bacterial biofilms through
complementary electrostatic interactions as well as stabilized the therapeutic payload of
the capsules through the formation of Schiff bases. Overall, these examples highlight the
potency of using supramolecular strategies for the intelligent design of nanomaterials.
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CHAPTER 1
ASSEMBLING FUNCTIONAL NANOMATERIALS
1.1. Overview of Nanoscale Materials
Nanomaterials are defined as objects that possess a component with at least one
dimension in the nanometer length scale. These nanoscale materials are particularly
attractive since they display unique physiochemical properties not achievable with bulk
material analogues.1 Examples of commonly used nanoscale materials are shown in
Figure 1.1. The large surface area to volume ratios possessed by nanomaterials make
them advantageous materials for catalytic,2 therapeutic,3 sensing,4 and electronic
applications.5

Furthermore, the biologically relevant scale of nanomaterials can be

employed to interface and interact many biological structures, such as cell membranes
and proteins, to provide unique insight into the underlying behaviors.6 The following
chapter will focus on the materials and methods that served as the background for this
thesis.

Figure 1.1: A space filling model of bovine serum albumin, a scanning electron
micrograph of silica nanoparticles, and a thin protein film on a silica wafer are shown as
representative nanomaterials.
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1.1.1. Proteins
Proteins provide a naturally occurring nanoscale building material. Most proteins
are constructed using 100-500 of amino acid building blocks or residues. The individual
amino acids possess side chains of varying functionality. These groups give the amino
acids their unique chemical properties.

The order in which the amino acids are

sequentially arranged is described as the primary structure of the protein. Dependent on
this ordering of the side chains, segments of the polymer assemble into various structures
due to van der Waals, hydrogen bonding, electrostatic, hydrophobic, and disulfide
crosslinking interactions. These individual secondary structures of the protein, such as
alpha helices and beta-sheets, are further assembled into a tertiary structure that gives the
protein an overall structural character such as globular, fibrous, or random coil. Their
inherent structure and functionality allows their rapid incorporation into functional
materials.
Proteins serve a variety of biological functions including cell signaling, enzymatic
catalysis, and structural support of tissues. The behavior of the protein is dependent on
its tertiary structure. Proteins can be divided into 3 main classes: globular, fibrous, and
membrane proteins which correlates with their tertiary structures. Globular proteins are
primarily water soluble, generally spherical in three dimensional shape, and can be
transporter

proteins

as

well

as

enzymes.

Fibrous

proteins

are

structural

biomacromolecules that assemble to form connective tissues which are water insoluble.
Membrane proteins interact with biological membranes such as the cell’s phospholipid
bilayer to aid in cellular response to environmental stimuli.
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1.1.2. Nanoparticles
Nanoparticles possess unique physiochemical properties compared to bulk
materials.7 These size dependent characteristics of nanomaterials, as shown in Table 1.1,
give rise to a variety of phenomenon such as quantum confinement of photons,8 enhanced
permeation and retention within cancerous tissues,9 and superparamagnetic behavior of
transition metals.10 Furthermore, the behavior of nanoparticles depends greatly on the
surface functionalization of the nanoparticle.11 The chemical moieties present at the
surface of nanoparticles can be tailored to regulate biological processes, such as
exocytosis, as demonstrated by the work of Rotello et al.12 Additionally, Mirkin and
coworkers have shown that DNA functionalized nanoparticles can be “crystallized” into
larger assemblies through rational design rules of the surface chemistry of the individual
nanoparticles.13
Table 1.1: Metal and semiconductor nanoparticles commonly used for biological
applications and their corresponding properties. Reprinted from Ref. 7 with
permission from Wiley‐VCH Verlag GmbH & Co.
Core
material

Characteristics

Ligand(s)

Ag

Optical absorption,
fluorescence and fluorescence
quenching, stability
Surface-enhanced fluorescence

Pt

Catalytic property

CdSe

Luminescence, photo-stability

Au

Thiol, disulfide,
phosphine, amine
Thiol
Thiol, phosphine,
amine, isocyanide
Thiol, phosphine,
pyridine

Fe2O3

Magnetic property

Diol, dopamine
derivative, amine

SiO2

Biocompatibility

Alkoxysilane
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Applications
Biomolecular
recognition, delivery,
sensing
Sensing
Bio-catalyst, sensing
Imaging, sensing
MR imaging and
biomolecule
purification
Biocompatible by
surface coating

1.1.3. Thin Films
Thin films of polymeric materials have been used for a variety of applications
such as antifouling coatings,14 photovoltaics,15 and biosensors.16 These films offer a
tailorable interface to alter the functional, mechanical, and biological behavior of
substrates in a modular fashion.17 As demonstrated in Figure 1.2, a thin film can be held
together by a variety of supramolecular forces between the individual components
comprising the film.18 In addition, the layers of materials assembled on surfaces often
vastly alters the properties of the underlying substrate.19 The chemical structure of the
layer material, method used for coating the underlying substrate, and postfunctionalization can all be used to modify the final behavior of the thin film.20

Figure 1.2: Schematic depiction of methods used to form Layer-by-Layer (LbL) films.
Supramolecular interactions between the polymers within the film affect the behavior of
the overall device. Spray-LbL is an example of rapid method to deposit these films on
medical devices. Reprinted from Ref. 18 with permission from Wiley‐VCH Verlag
GmbH & Co.
Thin films are particular attractive scaffolds for creating biomaterial coatings. For
instance, the surface functionality of thin films has been shown to modulate immune
4

response,21

protein

adsorption,22

and

affect

cellular

adhesion/behavior.23

Biodegradability can also be tuned to create controlled release drug platforms.24 For
example, Hammond et al. demonstrated that thin polymer coatings on bone implants that
contain osteoconductive hydroxyapatite and osteoinductive recombinant human bone
morphogenetic protein-2 effectively induced integration of the implant into the host
tissue.25

Overall, the surface functionalities of the components of the thin film tend to

dictate the performance of the film. Therefore, expanding the range of incorporable,
biocompatible polymers to form stable films would greatly improve the field.
1.2. Nanoscale Fabrication Techniques
The two basic methodologies for the generation of nanomaterials can be classified
as either “bottom-up” or “top-down” approaches.26 Bottom-up approaches rely on the
spontaneous assembly of smaller components into larger materials dependent on the
interactions between the individual constituents. Top-down methods, on the other hand,
reduce larger substrates into smaller units via etching, milling, or other physical removal
of surface elements from the initial material. As shown in Figure 1.3, both of these
strategies can be used to generate similar structures albeit via diametrically opposed
pathways. Bottom-up assemblies generate feature sizes that cannot be created following
a top-down approach. Structures that are formed from top-down approaches can be
achieved on much larger substrates and more rapidly than bottom-up approaches can
produce.
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Figure 1.3: Analogies for the production of a statue via bottom-up and top-down
fabrication methods: a) Lego pieces can be connected to build a sculpture in a similar
fashion that surfactant molecules can self-assemble into micellar structures. b) Marble is
sculpted from a larger block to reveal the stone statue within in much the same way that
an AFM tip can be used to carve patterns into silicon substrates. Reprinted from Ref. 26
with permission from the RSC.
1.2.1. Bottom-up Assembly
Bottom-up assembly employs small building blocks that self-organize into larger
structures. For example, DNA origami nanodevices,27 liposomes,28 and metal-organic
frameworks29 are widely used nanomaterials that depend on combining individual
components to create synergistic constructs. These assemblies are held together by noncovalent interactions, such as Van der Waals forces, hydrogen bonding, metal
coordination, and electrostatic interactions.30

The non-covalent nature of these

interactions give rise to a variety of dynamic assemblies. In particular, the protean
surface chemistry of nanomaterials offers a versatile palette to subtly influence biological
behaviors at the molecular level.31
Rotello et al. have developed a variety of sensors based on the selective
interactions of surface functionalized gold nanoparticles with biological systems.32,33 An
6

unbiased sensor array based on the electrostatic interactions between an anionic
fluorescent probe and multiple cationic functionalized gold nanoparticles was developed
initially for cancer cell sensing. Complexation with the nanoparticle reversibly quenches
the fluorescence of the probe. Following incubation with cells in a 96 well plate, the
fluorescence of the probe is regenerated due to competitive binding for the nanoparticle
surface (Figure 1.4). This selective response can also be used to differentiate bacteria and
bacterial biofilms indicating the generality of this sensing strategy across biological
systems.34,35

These cationic gold nanoparticles have also been shown to reversibly

control the catalytic activity of the enzyme β-galactosidase.36

The complementary

electrostatic interactions between the anionic β-galactosidase and the cationic
nanoparticles is disrupted in the presence of bacteria generating an enzymatically
amplified signal.37

Figure 1.4: Sensor array formed through the self-assembly gold nanoparticles and
fluorescent probes. Sample differentiation and classification is accomplished by
combining the individual responses from wells each containing differently functionalized
nanoparticles and performing statistical analysis to the data. Reprinted from Ref. 38 with
permission from Elsevier.
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1.2.2. Top-down Assembly
Top-down assembly strategies rely on taking a larger substrate and dividing it into
smaller pieces. The smaller components are made through the slicing, etching, or cutting
of the raw material.

Common top-down nanomanufacturing approaches are inkjet

printing,39 photolithography,40 dip-pen nanolithography,41 and nanoimprint lithography.42
The processing steps transfer a ‘master’ pattern unto the substrate generating the final
structure. The attainable feature sizes and complexities of the patterns is dependent on
the resolution of the manufacturing technique used.
Nanoimprint lithography is a particularly promising technique due to its low cost,
simplicity, and high-throughput potential.43 The process, as shown in Figure 1.5, is
accomplished by physically deforming a thin polymer film with a patterned mask under
high temperature and pressure.44

The polymer film is reorganized to replicate the

nanometer sized features of the mask. The transferred patterned polymer film can be
used for a range of fields such as controlled cellular behavior,45 photonics,46 and
magneto-optics.47
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Figure 1.5: Schematic of the NIL process. Reprinted from Ref. 44 with permission from
Wiley‐VCH Verlag GmbH & Co.
1.3. Protein Film Based Materials
Thin films of proteins are often fabricated through the self-assembly or
crosslinking of individual protein molecules. Protein films are widely used in a variety of
applications such as artificial organs,48 drug-releasing patches,49 and food packaging.50
Proteins that self-assemble in nature (e.g. amyloidogenic,51 silk proteins,52 collagen,53 and
fibrinogen54) provide particularly attractive scaffolds, combining biodegradability and
biocompatibility in materials comprised entirely of natural precursors. The remarkable
stability of these proteins is generally attributed to β-sheet rich regions in the peptide
backbone that aggregate to form the resultant film. These attributes have made these
protein-based materials especially promising materials for interfacing with cells for tissue
engineering55 and wound healing56 applications. Soy protein scaffolds have been used
for tissue regeneration,57 collagen-based scaffolds have been employed for culturing
retinal epithelial cells,58 and both collagen and chitosan-gelatin scaffolds have been used
for making artificial skin.59 Amyloid-forming proteins likewise provide a useful
9

platform.60 For example, Welland’s group demonstrated a scalable self-assembly
approach to make free-standing films from amyloid protein fibrils.51 Langer et al. have
fabricated micropatterned cellular co-cultures by using layer-by-layer deposition of
hyaluronic acid and fibronectin (Figure 1.6). This co-culture system allowed researchers
to study complicated cell behaviors, including cell-cell communication.61

Figure 1.6: a) Co-culture systems were fabricated using capillary force lithography
followed by the layer-by-layer deposition of hyaluronic acid and fibronectin. b) Cells
were fluorescently stained, AML 12 (green) and NIH-3T3 (red), to show the spatial
distribution of each cell type. Reprinted from Ref. 61 with permission from Elsevier.
Outside the small number of self-assembling proteins, most proteins generate
films that are not stable under aqueous conditions severely limiting their potential
biomaterial applications.62 One strategy to improve the stability of protein films is to use
covalent crosslinkers,63 including glutaraldehyde,64 formaldehyde,65 and glyoxal.66
However, these treatments can compromise the behavior of the films, and residual free
linkers or those released from the hydrolysis of film can cause toxic effects.67
Alternatively, side chain modification can be used to impart stability to protein films.68
As shown in Figure 1.7, Chen’s group demonstrated that soy proteins modified with
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diethoxyphosphoryl groups feature enhanced film stability. UV crosslinking can also be
used to stabilize films, though the irreversible chemical modification to the protein that
will occur using this process limits the biocompatibility of the film.69

Figure 1.7: Photographs demonstrating the stability of the native soy protein film a), at
50 % humidity and b) in the wet state. Photographs demonstrating the stability of the
chemical modified soy protein film c), at 50 % humidity and d) in the wet state.
Reprinted from Ref. 68 with permission from the RSC.
Heat curing of proteins is a straightforward technique to generate water-stable
films.70 Many approaches have used elevated temperatures to form soy,71 amaranth,72
and whey protein73 films. However, the temperature of the treatment greatly affects the
stability of the protein film, and can lead to unwanted chemical reactions such as the
Maillard reaction.74

In addition, heat curing often results in significantly denatured

protein films.75 Therefore, the development of new methods that could incorporate a
11

broader set of proteins, without compromising the structural integrity of the protein,
would vastly expand the biomaterial potential of films comprised solely of proteins.

1.4. Colloidal Assembly at Liquid/Liquid Interfaces
The boundary between two different phases is a thermodynamically constrained
condition. This unstable interface will reorganize the interacting molecules in order to
achieve a lower energetic state. Colloidal particles localize at these interfaces, such as
between immiscible liquids, to minimize the free energy of overall system. (Figure 1.8a)
This phenomenon was first observed by Ramsden76 and Pickering77 at the turn of the 20th
century and the structures were then identified as “Pickering emulsions.” This bottom-up
assembly strategy has been used to create a variety of stable structures such as catalysts,78
drug delivery vehicles,79 and microreactors.80 Pieranski demonstrated that this observed
stability due to the decreased interfacial energy could be explained with the following
equation:81
∆𝐸 = 𝜋𝑟 2 𝛾𝑜⁄𝑤 × (1 − cos 𝜃)2
The major factors in Equation 1 that contribute to minimizing the interfacial
energy of colloidal interfaces are the effective radius of the particle (r), the surface
tension between the oil and water phases (γo/w), and the wettability of the particle surface
(i.e. contact angle θ of the particle at interface as shown in Figure 1.8b). The greater the
diameter of particle used to stabilize the interface, more likely the particle is to resist
displacement by thermal fluctuations in the system. This behavior is due to the greater
amount of work required to remove a larger particle from the interface and disperse it
into the mother liquor than is required for a smaller particle. Adjusting the wettability of
the particle through surface functionalization and modification to generate more
12

amphiphilic particles, ideally a contact angle θ = 90°, can also be used to further improve
the stability of the emulsion.82

Typically, hydrophilic NPs stabilize oil-in-water

emulsions and hydrophobic NPs are used to stabilize water-in-oil emulsions.

Figure 1.8: Schematic illustration of Pickering emulsions. a) Particles self-assemble at
the oil/water interface to form stable emulsions. b) Isotropic particle present at the
oil/water interface.
1.5. Dissertation Overview
The research described herein will focus on tuning of the molecular interactions
of nanoscale building blocks to create highly versatile systems. Chapter 2 describes the
development of a generalized protein film stabilization strategy using nanoimprint
lithography. Both processing conditions used during fabrication as well as the structure
of the protein precursor were shown to influence the stability and cytophilicity of the
resultant films.

Chapter 3 expands on the selective mammalian cell adhesion

demonstrated by films of the individual proteins by introducing a modular inkjet printing
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deposition technique to generate tunable biomaterial surfaces. Chapter 4 describes the
development of a supramolecular construct to enhance the human olfactory system
beyond our antediluvian limitations. Chapter 5 provides a Pickering emulsion based
method to create discrete inorganic-organic microparticles for the retention of
hydrophobic payloads. Finally, Chapter 6 discusses the generation of a nanoparticlestabilized capsule based assembly for treatment of bacterial biofilms.
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CHAPTER 2
ROBUST PROTEIN FILMS GENERATED VIA NANOIMPRINT
LITHOGRAPHY
2.1. Introduction
Protein-based materials provide a uniquely biocompatible and sustainable
platform for the generation of functional materials.1,2,3,4 The intrinsic structural and
functional diversity inherent to proteins make them highly versatile building blocks.5
Prior research has harnessed the innate biocompatibility of protein films for applications
as diverse as bioelectronics,14 tissue engineering,10,11,16 and drug delivery.13,15 Proteins
also possess aqueous processability6 and have minimal environmental impact,7 making
them ideal components for sustainable "green" materials.

Translating these

characteristics into protein films resistant to aqueous degradation is crucial for most
applications such as tissue engineering and controlled drug delivery.8,9,10,11,12
Current methods to stabilize protein films use two main strategies: employing a
relatively limited range of naturally self-assembling proteins2,3,4 or using added
crosslinkers.13,14,15,16,17

Naturally-assembling proteins, such as silk fibroin, can be

processed into a multitude of biocompatible structures, though post-functionalization is
often needed to diversify the surface chemistry of the films.18

The latter covalent

crosslinking strategy generates polymeric complexes from a variety of proteins, however,
unreacted additives retained in the crosslinked protein films can adversely affect their
final behavior.18,19,20,21 Therefore an alternative methodology to stabilize protein films
would vastly expand the functional toolkit for creating biomaterials.
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We demonstrate here a scalable, additive-free nanoimprint lithography (NIL)
based method for the fabrication of stable, patterned protein films. This approach is
general in terms of protein building block, with the imprinted proteins retaining much of
their native structure and hence materials properties. The surface charge of the films can
be programmed through choice of protein, as demonstrated though Kelvin probe force
microscopy.

Simultaneously, the stability and degradability of these materials is

controlled through parametric variation of processing temperature and pressure. The
ability to utilize these materials properties is highlighted through generation of effective
non-fouling surfaces and tuning of cellular adhesion through choice of protein precursor.
2.2.Results and Discussion
We hypothesized that the combination of temperature and pressure provided using
thermal NIL could be used to create stable protein films with minimal loss of protein
structure, and without the use of additives. This NIL-based strategy for generating
protein films would allow us to greatly expand the range of protein building blocks from
the subset of naturally self-assembling proteins to the full range of readily available
proteins. Importantly, retention of protein structure in the NIL process would provide
effective translation of protein properties, such as surface charge, to the macroscopic
properties of the films.

These hypotheses were tested using three readily available

proteins that do not natively self-assemble: anionic bovine serum albumin (BSA, MW
66.3 kDa, pI 4.8), neutral hemoglobin (Hemo, MW 64.5 kDa, pI 6.8), and cationic
lysozyme (Lyso, MW 14.3 kDa, pI 11).
Precursor protein films were generated by spin-casting 10 % w/w aqueous
solutions of protein onto plasma cleaned substrates (Figure 2.1a). The films were ~200
21

nm in thickness as determined by ellipsometry and atomic force microscopy (Figure 2.2).
The spin-cast films were next imprinted/embossed by using a fluorosilane-functionalized
mold.

The NIL conditions were parametrically varied to identify the factors that

determine the aqueous stability of the imprinted protein films (Figure 2.1b); the results
demonstrate that both pressure and heat are required for generating stable protein films, a
synergistic behavior that had not been previously probed. Stable films were generated
from all three proteins at temperatures greater than 140 °C and pressures of 2.8 MPa,
with variation observed in the pressure/temperature profile of the individual protein, a
natural consequence of the dramatically differing structures of the precursor proteins.
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Figure 2.1: Method and optimized conditions used for imprinted protein film fabrication.
a) Proteins were spin-cast and then imprinted/embossed using temperature and pressure
to generate stable planar and patterned surfaces. These surfaces retain properties of the
precursor proteins that can be employed for a range of applications. b) Plots showing the
effect of pressure and temperature on film stability in water. Films were washed for 1 min
with water and the thickness measured by ellipsometry after drying, with water stability
observed only when heat and pressure are combined.
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Figure 2.2: AFM images and cross-sections of scratched protein films. The protein films
made by BSA, Hemo, and Lyso were scratched by blade and the film thicknesses were
determined by measuring the height differences made by scratching.
The secondary protein structure of the components within the films was
characterized using circular dichroism (CD) spectroscopy.22 (Figure 2.3a-c)

The

substantial retention of secondary structure indicates that a more subtle mechanism of
film stabilization than complete denaturation is operative.

We hypothesize that the

elevated temperature of the nanoimprinter causes flexibility of the random coil segments
of the peptide backbone, while the pressure limits conformational reorganization of the
protein structure. The origin of the film stability was probed through use of traditional
protein denaturants. Treatment of the films with 2-mercaptoethanol did not disrupt the
films, ruling out inter-protein disulfide bonds as the stabilizing factor.23 In contrast,
treatment with a surfactant (sodium dodecyl sulfate, SDS) rapidly disrupted the films,
indicating that inter-protein hydrophobic interactions imparts the observed stability of the
film to aqueous media.24 (Figure 2.4)
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Figure 2.3: Structural characterization of protein films a) CD spectra of BSA. b) CD
spectra of Hemo. c) CD spectra of Lyso. The individual proteins in phosphate buffer are
also shown for comparison. d) Surface potential of individual protein films as
determined by Kelvin probe force microscopy (KPFM). e) Thickness change in protein
films measured by ellipsometry after 48 hrs of incubation in 10 % serum solution. f)
Thickness change in protein films measured by ellipsometry after 24 hrs of incubation in
0.01 % trypsin solution.
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Figure 2.4: Thickness changes of protein films after incubating with 0.5 M 2mercaptoethanol (2-ME) and 10% sodium dodecyl sulfate (SDS) for 48 hours. The
thickness was measured by ellipsometry and the percentage changes were calculated by
comparing the thicknesses of protein films before and after treating with 2-ME or SDS.
SDS was used for disrupting hydrophobic interaction and 2-ME was able to break
disulfide bonds of protein films. The results indicated that the protein films were
stabilized mainly by hydrophobic interactions.
The retention of protein structure in the imprinted films implied that the choice of
protein could be used to dictate the charge of the resulting macroscopic films, an
important tool for numerous applications. Kelvin probe force microscopy (KPFM) 25 was
used to measure the local work function difference between the metallized probe (Pt) and
the protein surfaces.26 Figure 2.3d (along with Figure 2.5) shows histograms of measured
surface potential contrast (SPC) relative to the evaporated gold supporting substrate. As
expected based on precursor protein charge, the BSA surfaces present a negative surface
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potential, while the Lyso film possesses a positive surface potential. Hemo showed a near
neutral potential, consistent with its near neutral pI. The retention of charge was further
probed through charge-selective adhesion of positively and negatively charged quantum
dots (Figure 2.6), supporting that the surface charge differences established by KPFM
translate into functional control of adhesion.

Figure 2.5: Kelvin probe force microscopy analysis of the protein films. a) Surface
potential contrast measurement of gold substrate. Below is the line section profile. b)
Surface potential contrast measurement bovine serum albumin. Below is the line section
profile. c) Surface potential contrast measurement of hemoglobin. Below is the line
section profile. d) Surface potential contrast measurement of lysozyme. Below is the
line section profile.
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Figure 2.6: Adhesion of functionalized quantum dots (QDs) to protein films. a) The
chemical structures of surface functionalities on QDs. The charged QDs were used as
probes for the surface charges of protein films by interacting with protein films through
electrostatic interaction. b,c) 10 µL 1 µM QD probes were dropped on the protein films
and incubated for 15 mins in a humid chamber to avoid drying. After incubation, the
protein films were washed by Milli-Q water 5 times. Then the surface charges of protein
films were determined by the fluorescent responses under the irradiation of a UV lamp at
365 nm. For the BSA film, only the positively charged probe showed a strong
interaction, indicating that BSA film is negatively charged. The Lyso film showed the
opposite result due to its inherent positive charge.
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We next focused on biomaterial applications for these NIL protein films. The
inherently zwitterionic surfaces of soluble proteins is essential in inhibiting their
aggregation in solution.1 The retention of surface properties should therefore provide
resistance to protein fouling, an important requirement for both implantable devices and
for ex vivo applications.27,28 We evaluated resistance to protein deposition of our films by
incubating films in 10 % serum solutions for 48 hrs and then measuring the film
thicknesses by ellipsometry. As shown in Figure 2.3e, there were no significant increases
in film thicknesses, indicating that the films are resist non-specific protein adsorption.
We further tested the response of the films to the intracellular protease trypsin, as
controlled degradation of scaffolding plays an important role in interfacing materials with
biological systems.12,14 After incubating in 0.01 % w/w trypsin solution for 24 hrs, BSA
and Hemo films fabricated at 180 °C were resistant to trypsin hydrolysis. All films
imprinted at 150 °C, however, were degraded (Figure 2.3f), making these films
promising candidates for controlled-release applications.29
Previous studies have demonstrated that charged molecules on surfaces are
important for directing cellular adhesion, with more efficient attachment observed with
positively charged surfaces.30 Based on our ability to control the surface charge of the
imprinted protein films, functional demonstration of the differences in film properties
was obtained through cell adhesion studies. NIH-3T3 fibroblast cells were seeded onto
protein films for 48 hrs and stained with calcein-AM. Fluorescence microscopy images
show that films made from negatively charged BSA and neutral Hemo cells had limited
adhesion on films fabricated at 150 °C (Figure 2.7a) while the films fabricated at 180 °C
(Figure 2.7b) demonstrated no measurable adhesion. In contrast, Lyso films provided
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excellent adhesion at both processing temperatures, consistent with the expected higher
cellular adhesion by the cationic surface.30

Figure 2.7: Cellular adhesion to protein films. Adhered cells on protein films generated
at a) 150 °C and b) 180 °C were stained with calcein-AM after 48 hrs. Scale bars
represent 100 µm.
The NIL process used in our method provides direct access to nanoscale
patterning that can be used to dictate cellular alignment, a feature that subsequently can
be translated into tissue formation.30 Based on the cellular adhesion studies, Lyso was
chosen to investigate cell alignment based on nanopatterning. As shown in Figure 2.8a
inset and Figure 2.9a, the Lyso film was texturally patterned using a fluorosilanefunctionalized master mold with a 300 nm grooved pattern. Next, NIH-3T3 fibroblast
cells were cultured onto the patterned film. As shown in Figure 2.8b and Figure 2.9b,
cells were fixed, stained with phalloidin to visualize actin filaments, and alignments were
measured by optical microscopy. Figure 2.8a shows that a majority of the cells aligned
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with the nanoscale pattern, demonstrating that the film properties and patterning provided
by the NIL process can be used synergystically to direct cellular growth.

Figure 2.8: Cellular adhesion and alignment with patterned surfaces. a) Percentage of
cells aligned along the imprinted pattern. Inset is a 3D atomic force microscopy image of
the Lyso film generated with a patterned mold. b) Fluorescence micrograph of fibroblast
cells cultured on the patterned Lyso film. Cell nuclei were stained with Hoechst 33342
and actin filaments were stained with phalloidin.
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Figure 2.9: Cell culture adhesion and cellular alignment with patterned surfaces. a) 3D
atomic force microscopy image of the lysozyme film generated with a patterned mold. b)
Fluorescence micrograph of fibroblast cells cultured on the patterned lysozyme film.
Hoechst (left) was used to stain cell nuclei and phalloidin (right) to stain actin filaments.
Scale bars are 50 µm.
2.3. Conclusions
In summary, we have demonstrated that the controlled heat and pressure provided
by thermal NIL generates water-stable films from a range of precursor proteins. These
films are generated without additives and in an environmentally benign fashion. The
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proteins retain substantial native protein structure, which renders them biocompatible and
resistant to protein fouling. The films also integrate the intrinsic physical properties of
the precursor proteins, allowing surface charge and stability to be tuned by choice of
precursor protein and processing conditions. This bottom-up method is generalizable,
indicating it can use the enormous variety of naturally occurring and engineered proteins
to generate films with a commensurate range of properties. Furthermore, the readily
scalable NIL based method is multimodal, as the process both influences the stability of
the films and introduces nanoscale architectural features. Taken together, the ability to
generate stable protein films using NIL provides an enabling technology for a broad
range of applications ranging from biomedicine to sustainable consumer materials.
2.4. Experimental Methods
2.4.1. Materials
BSA, Hemo, and Lyso were purchased from Fisher Scientific and used without further
purification. Silica wafers were purchased from WRS Materials. Quartz microscopy
slides were purchased from Electron Microscopy Sciences. MilliQ water was purified by
using a Millipore water purification system.
2.4.2. Film Preparation
10 % w/w solutions of protein in MilliQ water were filtered by using a 0.22 µm filter and
spin-coated at 3000 rpm for 60 s onto an oxygen plasma cleaned silicon substrate,
yielding a thin film of protein.
2.4.3. Nanoimprint Lithography (NIL)
Nanoimprinting of protein films was performed by using a Nanonex NX-2000
nanoimprinter with silicon molds. Imprinting was performed at various temperatures and
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pressures for 5 min. A silicon NIL mold (line width 303 nm, period 606 nm, and groove
depth 190 nm) from Lightsmyth Technologies was used in the cell patterning. All molds
were treated with heptadecafluoro-1,1,2,2-(tetrahydrodecyl)dimethyl- chlorosilane at 75
°C for 2 days in a vacuum chamber.
2.4.4. Kelvin Probe Force Microscopy (KPFM)
10 % w/w solutions of protein in MilliQ water were filtered using a 0.22 µm filter and
dropcast onto an oxygen plasma cleaned gold substrate, yielding a thin film of protein.
Nanoimprinting of the protein films was performed by using a Nanonex NX-2000
nanoimprinter with flat silicon molds at 180 °C and 2.8 MPa. The KPFM was conducted
with platinum coated tips (ANSCM-PA) purchased from AppNano on a Digital
Instrument atomic force microscope under ambient temperature and atmospheric
conditions.
2.4.5. Cell Culture
Mouse fibroblast cells 3T3 (ATCC CRL-1658) were cultured in Dulbecco's modified
Eagle's medium (DMEM; ATCC 30-2002) supplemented with 10% bovine calf serum
(ATCC 30-2030) and 1 % antibiotics in T75 flasks. Cells were maintained at 37 °C in a
humidified atmosphere of 5 % CO2 and were sub-cultured once in 4 days.
2.4.6. Cell Adhesion
3T3 cells grown in T75 flasks were washed with phosphate buffered saline (PBS),
trypsinized with 1X trypsin and collected in DMEM media. Cells were centrifuged and
were re-suspended in fresh DMEM media and counted by using a hemocytometer.
Protein film coated surfaces were placed in a six-well plate where 3T3 cells were added
to each well (100000 cells/well) and incubated for 48 h at 37 °C in a humidified
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atmosphere of 5 % CO2. Following incubation, cells were washed with phosphatebuffered saline (PBS) three times and incubated with calcein AM (Biotium Inc, 80011-2)
and propidium iodide (Invitrogen) in PBS (final concentration 3 μM each) for 30 min.
Fluorescence microscopy images were taken by using an Olympus IX51 microscope to
visualize the adhered live (Calcein AM stained, green) and dead cell (propidium iodide
stained, red) population in each surface.
2.4.7. Cell Alignment on Nano-patterned Surfaces
The cell alignment on the patterned surfaces were performed according to previously
published procedures.30 Briefly, 100000 cells were incubated with the nano-patterned
surface for 48 h and washed twice with pre-warmed PBS and fixed with 3.7 % methanolfree formaldehyde solution (Electron Microscopy Sciences 15714-S). Cells were then
washed three times with PBS and extracted with 0.1 % Triton X-100 in PBS for 5 min.
Surfaces were then washed with PBS and incubated with a solution of Oregon Green 488
phalloidin (Invitrogen O7466) to stain actin filaments and Hoechst nuclear stain
(Invitrogen H1399) at final concentrations of 200 nM and 1 μg/mL respectively in PBS.
After 30 minutes, the cells were washed three times and the images were captured using a
confocal microscope (Olympus). Cell alignment was measured by using ImageJ software
by determining the angle of the long axis of the nucleus with respect to the parallel
direction of the pattern. 45 random cells from each image were counted according to their
angle of alignment from 0 ° to 90 ° in 10 ° increments and their percentage distribution
was graphed.
2.4.8. Characterization

35

Bright field images and fluorescence were detected by using an Olympus IX51
microscope with excitation wavelengths of 470 nm and 535 nm. AFM imaging of the
surfaces was done on a Dimensions 3000 (Veeco) in tapping mode using a RTESP7 tip
(Veeco). Confocal images were obtained by using a Zeiss LSM 510 Meta microscope.
The film thickness of the protein films was measured by a Rudolph Research Auto EL
ellipsometer. Far-UV circular dichroism (CD) spectra were measured on a JASCO J-720
spectropolarimeter with a quartz cuvette of 1 mm path length at 25 °C. The spectra were
recorded from 200 to 260 nm as an average of three scans at a rate of 20 nm/min.
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CHAPTER 3
MIXED PROTEIN FILMS AS TUNABLE BIOMATERIAL PLATFORM
3.1. Introduction
Protein derived materials offer an inherently sustainable and structurally diverse
platform for the fabrication of functional materials.1,2,3 Protein films provide particularly
attractive scaffolds for biomaterials, combining biodegradability and biocompatibility in
versatile materials comprised of natural precursors.4,5,6 Furthermore, the protein surface
creates a molecular template for controlling interactions with biological systems.7,8,9
These favorable attributes have made these protein-based materials highly amenable to
interface with cells for tissue engineering10,11 and wound healing12,13 applications.
Recently, we have developed an additive free, nanoimprint lithography (NIL)
based method for the generation of water stable protein films.14 Based on previous
studies of patterned and multicomponent thin films,15,16,17 we hypothesized that inkjet
printing of proteins would provide a suitable method for the “direct-writing” of twodimensional biomolecular patterns to complement our NIL protein film fabrication
strategy.

Herein, we describe a combined inkjet printing based deposition with

nanoimprint lithography stabilization methodology generates materials surfaces with
tunable biological interactions. The utility of these films was demonstrated through the
controlled adhesion and migration of mammalian fibroblasts as well as bacteria. This
versatile nanomanufacturing platform is a promising system for the rapid prototyping of
new biomaterials with tunable surface properties.

39

3.2. Results and Discussion
Inkjet printing provides a reproducible method for controlling the mixing and
deposition of nanomaterials.18 Previous studies have demonstrated that proteins can
readily be inkjet printed without vastly altering the intrinsic properties of the protein.19
We hypothesized that the parametric control offered by inkjet printing would allow us to
dial in the biological response to combinatorial protein films. As shown in Figure 3.1,
inkjet deposition of protein-based inks generates micron-patterns whose components can
be modularly assembled. Following this directed deposition, the proteins are stabilized
into a functional film using an additive free, nanoimprint lithography based method that
is stable to cell culture conditions as described in Chapter 2. This NIL methodology is
crucial for film stabilization as the process is not dependent on the protein precursor used
and does not add biologically adverse substances to the film.

Figure 3.1: Schematic of film processing strategy to generate protein films. Inkjet
directed deposition controls both the film composition and spatial presentation of the
protein components.

40

We chose to probe cellular adhesion as a model biological response as the
regulation of cellular adhesion/migration has been shown to be a critical factor in a
variety of biological processes including cell differentiation.20 tissue development.21 and
cancer progression.22 Bovine serum albumin (BSA, MW 66.3 kDa, pI 4.8) and lysozyme
(Lyso, MW 14.3 kDa, pI 11) were selected as our model anionic and cationic protein
inks, respectively. Films were generated through the deposition of the protein inks in a
parametric fashion. Film composition was varied from 100 % BSA to 100 % Lyso in 20
% increments. Each ratio displayed a similar roughness and thickness indicating that the
surface interactions of the film with its environment should be entirely electrostatic in
nature. (Table 3.1)
Table 3.1: Thickness and roughness of protein films with different ratio of BSA
and Lyso. The thickness was measured using ellipsometry (n=5) and the roughness was
obtained by AFM.
Composition

Thickness (nm)

Roughness (nm)

100 % BSA

134.9 ± 0.3

0.55

20 % Lyso

134.2 ± 0.1

1.039

40 % Lyso

136.3 ± 2.6

1.095

60 % Lyso

136.8 ± 3.3

3.144

80 % Lyso

133.6 ± 0.4

4.829

100 % Lyso

134.8 ±1.1

0.72

The deposition of functionalized nanoparticles was quantified using laser ablation
inductively coupled plasma mass spectrometric imaging (LA-ICP-MSI) to probe the
successful incorporation of protein charge into the properties of the film.23,24 Surface
functionalized gold nanoparticles (AuNPs) are an ideal probe for understanding
supramolecular interactions at a biologically relevant scale.25 We incubated the films
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generated from varying ratios of proteins with AuNPs possessing either cationic or
anionic headgroups. Using LA-ICP-MSI, we characterized the adhesion of the AuNPs
with respect to their complementary interactions with each film constituent. As shown in
Figure 3.2a, b, the cationic AuNPs selectively adhere to BSA containing films whereas
the anionic AuNPs were adsorbed to the Lyso films. These results indicated that the
intrinsic protein charges were successfully incorporated into the film and the overall
property of protein film was tunable with respect to complementary electrostatic
interactions.
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Figure 3.2: Adhesion of a) cationic and b) anionic AuNPs as determined by LA-ICPMSI. Protein films were generated by varying the BSA:Lyso ratio of the film in 20 %
increments. Scale bars are 500 µm.
Next, we determined whether this physiochemical response to nanomaterial
interfaces was translatable to biological systems.

We quantified the adhesion of

mammalian fibroblast cells using films generated from increasing ratios of BSA:Lyso.
As shown in Figure 3.3, cells adhere to films generated with greater percentages of Lyso
with a drastic increase observed with films comprised of 80 % or more of Lyso. Films
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fabricated with higher BSA amounts demonstrated minimal adhesion confirming the
incorporation of protein charge into the overall materials properties of the film.

Figure 3.3: Adhesion of mammalian fibroblasts on films with varying ratios of protein
components. a) Cells were stained with Hoescht 33342 and Calcein AM to label the cell
nuclei and cytosol, respectively. Scale bars are 200 µm. b) Average number of cells per
mm2 as determined using image analysis. (see Figure 3.12)
We generated a gradient where the BSA:Lyso ratio was varied to further probe
the adhesion based on the composition of mixed protein component. As shown in Figure
3.4a, c, the cells preferentially adhere to the Lyso containing portion of the film.
Notably, the films ratiometric and gradient patterns demonstrate highly correlative results
underpinning the robustness with which biomaterial properties can be dialled in through
modular assembly.
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Figure 3.4: Adhesion of mammalian fibroblasts on micropatterned films. a) Cell
adhesion to protein film generated with a gradient pattern. Cells were stained with
Hoescht 33342 and Calcein AM to label the cell nuclei and cytosol, respectively. b) Cell
adhesion to patterned film with discrete Lyso and BSA domains. The solid line (Lyso)
and dotted line (BSA) were drawn to aid the eye. c) Number of cells with respect to
position along gradient as determined using image analysis. (see Figure 3.13) d)
Fluorescence micrograph of cells adhered to Lyso pattern surrounded by BSA. Scale
bars are 100 µm for a), 200 µm for d), and 1 mm for b).
Inkjet printing advantageously affords spatial control over the deposition of film
components. We deposited a rectangle of Lyso surrounded by a circle of BSA to probe
the dependence of cellular adhesion as a function of geometric deposition. As shown in
Figure 3.4b, d, the cells preferentially adhere to the Lyso pattern and can be easily
washed away from the BSA coated surface. This dynamic process of cellular attachment
was also observed at the boundary of BSA and Lyso patterns as shown in Video 3.1.
We next tested the generality of the observed selective adhesion using a model
bacteria strain, Escherichia coli DH5α (E. coli). The bacteria strain was induced to
express the red fluorescent protein td-Tomato in order to readily image the adhered
bacteria. As shown in Figure 3.5, the bacteria preferentially adhered to the lysozyme rich
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films. This observation is in agreement with previous studies that demonstrate the
negatively charged bacterial cell walls adhere to anionic surfaces.26

Figure 3.5: Fluorescence micrographs showing the adhesion of E. coli DH5α expressing
red fluorescent protein after 1 day of incubation. Scale bars are 50 µm.
3.3. Conclusions
In conclusion, we have developed a highly modular method to generate stable
protein films in a rapid fashion with diverse components. The environmentally friendly
processing taken with the parametric control over the surface chemistry provides a
multidimensional platform for understanding and controlling biological interactions with
protein coated surfaces.

Due to the minimal waste inherent to inkjet deposition

incorporating engineered proteins into robust, bioactive films. Additionally, this strategy
is readily translatable into a roll-2-roll methodology to generate biomaterials in a highthroughput fashion for potential wound healing and tissue engineering applications.
3.4. Experimental Methods
3.4.1. Materials
Bovine serum albumin (BSA) and lysozyme (Lyso) were purchased from Fisher
Scientific and used without further purification. Silica wafers were purchased from WRS
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Materials. Glass microscopy slides were purchased from Fisher Scientific. MilliQ water
was purified by using a Millipore water purification system.
3.4.2. Synthesis of TTMA and Carboxylate AuNPs
Gold nanoparticles were synthesized according to previously reported methods.27,28
Briefly, the Brust-Schiffrin two-phase synthesis method was used to synthesize
pentanethiol-coated AuNPs with core diameter ca. 2 nm.29,30 Murray place-exchange
method31 was followed to obtain the ligand-protected AuNPs. Pentanethiol-conjugated
AuNPs (20 mg) and thiol ligand (60 mg) were dissolved in a mixture of dry DCM (6 ml)
and methanol (2 ml) and stirred under N2 atmosphere for 3 days at room temperature.
The solvents were removed under reduced pressure and the resulting precipitate was
washed with hexane (20 ml) three times and DCM:hexane mixture (1:1 v/v, 20 ml) four
times. Then the precipitate was dissolved in distilled water (~ 8 ml) and dialyzed for
three days (membrane molecular weight cut-off =10,000, volume of the dialysis bucket is
5 L) to remove excess ligands, pentanethiol, acetic acid, and other salts present in the
nanoparticle solution.

After dialysis, the particle was lyophilized to yield a solid

brownish product. The particles were then re-dispersed in deionized water.
3.4.3. Mass Spectrometric Characterization of Ligand Composition
Matrix assisted laser desorption/ionization mass spectroscopy (MALDI-MS) has been
performed to characterize the surface ligand on the AuNPs (Figure 3.6 and 3.7).32 A
saturated α-Cyano-4-hydroxycinnamic acid (α-CHCA) stock solution was prepared in
70% acetonitrile, 30% H2O, and 0.1% trifluoroacetic acid. An equal volume of 2 μM NP
solution was added to the matrix stock solution. 2.5 μL of this mixture was applied to the
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sample carrier, and then the MALDI-MS analysis was performed on a Bruker Autoflex
III mass spectrometer.

Figure 3.6: Matrix-assisted laser desorption/ionization mass spectroscopy (MALDI-MS)
spectrum of TTMA NPs. [MH]+ = 422.33.

Figure 3.7: Matrix-assisted laser desorption/ionization mass spectroscopy (MALDI-MS)
spectrum of carboxylate NPs. [MH+2Na-H-H2S]+ = 449.25.
3.4.4. Dynamic Light Scattering (DLS)
DLS experiments and zeta potential measurements were performed using a Malvern
Zetasizer Nano ZS. Samples were sonicated prior to measurements.
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Figure 3.8: DLS measurements of TTMA NPs was obtained in 5 mM phosphate buffer at
pH 7.4. The average size was 10.3  2.42 nm.

Figure 3.9: Zeta potential of TTMA NP was measured by DLS in 5 mM phosphate buffer
at pH 7.4. The overall charge of this cationic TTMA NPs is measured as 21.1 ± 5.93 mV.
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Figure 3.10: DLS measurements of COOH NPs was obtained in 5 mM phosphate buffer
at pH 7.4. The average size was 10.2  2.06 nm.

Figure 3.11: Zeta potential of COOH NP was measured by DLS in 5 mM phosphate
buffer at pH 7.4. The overall charge of this anionic AuNPs is measured as -43.1  4.71
mV.
3.4.5. Inkjet Deposition of Protein Inks
The inkjet printing was done using an Epson Artisan 50 inkjet printer. The BSA and
Lyso were diluted to a concentration of 5 wt% with 80:20 volume ratio of water/ethanol
solution, filtered through a 0.2 µm polypropylene membrane (Puradisc 25AS, Whatman),
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and syringed into a virgin aftermarket Epson inkjet cartridge for printing (MIS
Associates, Auburn Hills, MI USA). For this work, the BSA solution was loaded in
magenta channel and the lysozyme solution was loaded in cyan channel. Printing was
done using an Epson Artisan 50 inkjet printer (Long Beach, CA USA) which was used as
packaged. The glass substrate was loaded into the printer by taping the bottom of the
substrate to the included CD tray. Patterning was done by using the Print CD software
provided with the Epson printer. In order to print only the channel of interest, the color of
the pattern has to match the channel printed. To print only the magenta channel, the RGB
value must be set to (255,0,255); the cyan channel, (0,255,255).

The ICM color

management also must be turned off in the Advanced tab of the printer properties to
ensure no mixing of the channels occurs. To print BSA/Lyso mixed patterns, the ratio of
magenta/cyan were converted into corresponding RGB value on the website:
http://web.forret.com/tools/color.asp. The gradient pattern from 100% BSA to 100%
Lyso was made by color gradient tool in the Print CD software. Before printing, the
printheads were cleaned two times using the “Head Cleaning” function in the
Maintenance tab of the printer properties to ensure that the channels were filled.
3.4.6. Nanoimprint Lithography
Nanoimprinting of protein films was performed by using a Nanonex NX-2000
nanoimprinter with flat silicon molds. Imprinting was performed at 180 °C and 2.8 MPa
for

5

min.

All

molds

were

treated

with

heptadecafluoro-1,1,2,2-

(tetrahydrodecyl)dimethyl-chlorosilane at 75 °C for 2 days in a vacuum chamber prior to
use.
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3.4.7. Cell Culture
NIH 3T3 cells were cultured in a humidified atmosphere (5 % CO2) at 37 °C, and grown
in Dulbecco’s modified Eagle’s medium (DMEM, low glucose) supplemented with 10 %
fetal bovine serum (FBS) and 1 % antibiotics (100 U/mL penicillin and 100 μg/mL
streptomycin).
Cell adhesion experiments were performed by incubating 150,000 NIH 3T3 cells with
protein coated silica wafers placed in a 12-well plate for 1 h. The surfaces were then
washed by cold phosphate buffer saline (PBS) 3 times to remove floating cells, followed
by incubation with 1 mL of fresh media for 23 h. Cells were then stained with Calcein
AM and Hoescht 33342 to label cytosol and nucleus, respectively, for fluorescent
microscopic imaging according to the protocol from Life Technology using an Olympus
IX51 microscope with excitation wavelengths of 470 nm and 535 nm.
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Figure 3.12: Cell counting data on mixed protein films of varying protein ratios were
obtained using ImageJ software. Box dimensions are 250 µm x 250 µm.
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Figure 3.13: Cell counting data on gradients were obtained using ImageJ software. Box
dimensions are 1000 µm x 200 µm.
Live cell video imaging was performed by incubating 300,000 NIH 3T3 cells with
protein patterned glass slides in a 35 mm petri dish for 1 h. Slides were then washed with
PBS 3 times to remove floating cells, the petri dish was filled with 4 mL of fresh media
and placed into a CO2 chamber with temperature control on the microscope. Optical
images of cells were then continuously recorded using an Olympus IX51 microscope
every 15 min for 8 h.
3.4.8. Bacteria Adhesion Studies
Bacteria were inoculated in 3 mL LB broth and grown to stationary phase at 37 °C. The
cultures were then diluted in M9 broth supplemented with 1 mM IPTG (isopropyl β-D-1thiogalactopyranoside). 2 mL of the dilution was transferred into the wells of a 24 well
plate containing Silicon coated surfaces (22 × 22 mm). The 24 well plate was kept at 25
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°C and the biofilms were allowed to grow for 24 hours. In general, the surfaces with
biofilms were rinsed in deionized water for three times before imaging.
3.4.9. Inductively Coupled Plasma Mass Spectrometry Imaging
For the characterization of the nanoimprinted protein samples, we used laser ablationinductively coupled plasma mass spectrometry (LA-ICP-MS) imaging. Imaging was
done using a CETAC LSX-213 G2 laser ablation system (Photon Machines, Omaha, NE,
USA) attached via a 2 m length of tubing to a Perkin Elmer NEXION 300X ICP mass
spectrometer. Prior to analysis of the samples, we dropped a 1 µL of TTMA and COOH
functionalized AuNPs separately.

Then, using imaging, we generated Au map

distribution of these AuNPs on the nanoimprinted surfaces. The parameters used for the
imaging experiment can be found on Table 3.2.
Table 3.2: Experimental conditions used for LA-ICP-MS analysis.
Laser ablation parameters
Spot size
50 µm
Scan rate
10 µm/s
Laser energy
3.34 J
Frequency
10 hz
Carrier gas flow 0.6 L/min
rate (Helium)

ICP-MS parameters
Rf power
1.6 kW
Nebulizer flow rate 0.7 L/min
Plasma flow rate
16.5 L/min
Auxiliary flow rate 1.4 L/min
Pulse and Analog 950 V(Pulse),
stage voltages
-1600 V(Analog)
Deflector voltage
-12 V
Dwell time
50 ms

Using the parameters show on the Table 3.2, imaging experiments were performed to
obtain Au maps of the samples. The results obtained from ICP-MS analysis were further
processed using Excel and then images of the samples were generated using ImageJ
software. To obtain quantitative images of the samples, chicken breast tissues were
purchased from a local market and they were homogenized using PowerGen 125
homogenizer. Homogenized tissues were centrifuged at 12000 rpm for 5 minutes and the
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powders precipitated were collected. 5 aliquots of 50 mg of homogenate were weight
and placed into 0.5 mL tubes. Different concentration of AuNPs (0, 0.125, 0.25, 0.5 and
1µM) were injected into these 50 mg aliquots and frozen to be sliced. The frozen block
of sample then sliced to 12 µm thickness using a LEICA CM1850 cryostat. The sliced
tissues were imaged under the same conditions following the analysis of the
nanoimprinted samples.
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CHAPTER 4
NANOZYME-BASED OLFACTORY SYSTEM ENHANCER (NOSE)
4.1. Introduction
Odorous compounds function as potent sensory agents eliciting almost
immediate and primal human responses.

The human olfactory system has

evolved to be capable of detecting extremely low concentrations of volatile
organic compounds present in complex environments.1 Furthermore, humans can
discriminate more than 1 trillion olfactory stimuli, several orders of magnitude
greater than their capability of visual discrimination.2 For example, the aromatic
compounds generated during the Maillard reaction offer rare insights into the
countless chemical transformations that occur during this redolent process. 3,4
However, a variety of biological and non-volatile chemical interactions are
transient and remain undetectable to humans without these small molecule
products.5

Consequently, translating reversible molecular events into a signal

that is interpretable by the human olfactory system continues to be an elusive
goal.
Nanotechnology provides a unique avenue to redefine the bounds of
human perception.6 In particular, engineering the surface of nanomaterials is a
powerful strategy to direct interactions at the molecular level.

7

Previously,

surface functionalized gold nanoparticles have been used to generate array-based
sensors,8 regulate enzymatic activity,

9

and influence cellular growth on

surfaces.10 The proximate response to the nanomaterials has been shown to be
controlled in a surface moiety dependent fashion.11 Engineered nanomaterials
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have also been shown to influence the behavior of fragrance molecules.12 In a
recent study, Weder et al. demonstrated cellulose nanocrystals functionalized with
pro-fragrance molecules could be used to control the production of volatile
compounds.13 These covalently bound complexes remain odorless until certain
functional groups are cleaved in response to specific external stimuli to generate
the pungent aroma molecules.14

Taken together, we hypothesized that pro-

fragrances in combination with surface engineered nanomaterials could behave as
reactive constructs to translate molecular interactions into scent.
Herein, we describe a supramolecular-based approach to augment human
olfactory perception. The Nanozyme-based Olfactory System Enhancer (NOSE)
readily complements the high sensitivity innate with the human olfactory system.
The system is comprised of 3 tunable components: 1) pro-fragrance molecules, 2)
surface functionalized nanoparticles, and 3) enzymes to cleave the pro-fragrances.
The surface moieties of the nanoparticles behave as both selective recognition
elements for analytes present in solution and to reversibly inhibit the complexed
enzymes. This recognition tactic shifts the primary detection onus from the
olfactory bulb to the binding equilibrium established by the nanoparticle with the
protein which has been shown to be highly dependent tunable based the surface
functionality of the nanoparticle.15 We assessed the feasibility of our approach to
expand human sensory capabilities by developing an olfactory-based bacteria
sensor as a model supramolecular interaction.

The NOSE allowed human

subjects to detect bacteria in solution at levels as low as 102 cfu/mL indicating the
system could effectively enrich human olfactory faculties.
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4.2. Results and Discussion
We first sought to prototype our approach by creating a bacterial biosensor as
bacteria-related illnesses from inadequate drinking water sources and improper sanitation
practices contribute to over 1.5 million deaths worldwide a year.16,17 Our sensor design is
based on the selective activation of an inhibited enzyme in the presence of bacteria
(Figure 4.1). Specifically, the sensor components are a cationic surface functionalized
gold nanoparticle (AuNP), anionic Candida Rugosa lipase, and a pro-fragrance molecule,
succinic acid monophenylethyl ester (SAME). We chose AuNPs possessing ligands with
terminal benzyl headgroups as these nanoparticles have been shown to both interact with
the anionic cell surface of bacteria as well as inhibit enzymatic activity.18,19 We used
Candida Rugosa lipase as a model, industrially relevant enzyme due to its robust
characteristics and its ability to cleave ester bonds in a variety of conditions.20 Profragrances are volatile molecules that have been covalently modified to create a product
that will generate the precursor fragrance upon cleavage of the covalent bond.21 The
succinic acid ester of phenylethyl alcohol was chosen as our representative pro-fragrance
as it produces a pleasant rose scent upon cleavage and phenylethyl alcohol has a low odor
threshold.22 Figure 4.2 shows the NMR spectra of the synthesized pro-fragrance.
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Figure 4.1: Schematic representation of sensor elements used in this study. Cationic
AuNPs bind with the anionic enzyme inhibiting the catalysis of the pro-fragrance into
scent. Bacteria present in solution compete for the AuNP surface and displace the
enzyme inducing the production of the rose fragrance.
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Figure 4.2: 400 MHz 1H NMR spectrum of the pro-fragrance, succinic acid
monophenylethyl ester in chloroform-D (D-99.8 %). Spectrum was obtained on a Bruker
Avance 400 MHz, 16 scans.
We initially performed a colorimetric assay to optimize the lipase to AuNP ratio
needed for inhibition.

These studies were performed using a 0.15 nM lipase

concentration in sodium phosphate buffer solution (5 mM, pH 7.4) incubated with
various concentrations of benzyl AuNP for 30 minutes to generate the sensor complexes.
10 µL of the colorimetric substrate p-nitrophenylbutyrate (pNPB, [0.6 mM], λmax = 405
nm) was added to the sensor complexes. As shown in Figure 4.3, a 3:1 AuNP to lipase
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ratio completely inhibited the lipase. This AuNP:lipase ratio was used to generate the
nanozyme complex for all further studies.

Figure 4.3: Lipase inhibition assay in the presence of benzyl AuNP. The same amount of
lipase (15 nM) was incubated with a series of benzyl AuNP (from top to bottom: 0, 20,
40, 60, 80, 100, 125, 150 nM) before adding the colorimetric substrate p-NPB (0.6 mM).
After the substrate was added, the activity of lipase was monitored up to 2400 seconds
(40 minutes). A control of p-NPB without the enzyme did not produce a signal.
We used Escherichia coli XL1 (E. coli) as a model bacteria strain for our sensing
studies with human participants. Ten volunteers were asked to smell four different glass
vials at two time points (1 minute and 15 minutes to ensure olfactory clearance 23) that
contain four conditions: buffer, sensor only (AuNP and lipase), NOSE in a solution of E.
coli at 102 cfu/mL and sensor in a solution of E. coli at 104 cfu/mL. Solutions of the
sensor elements were incubated for 30 minutes prior to the addition of the pro-fragrance
and bacteria. Samples were then incubated for 15 minutes in 20 mL glass vials. Each set
of samples (four glass vials) was prepared individually for each participant. Volunteers
then used rank ordering to indicate the intensity of rose scent within the samples. They
ranked the samples in order from lightest smell to strongest smell with a scale from 1 to
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5. As shown in Figure 4.4, participants were successfully able to detect the rose scent in
the presence of uninhibited lipase. Notably, volunteers were able to detect E. coli
concentrations at both 102 and 104 cfu/mL.

Figure 4.4: Olfactory detection study in human. a) Lipase activity test in the presence of
SAME was carried out with six participants. SAME only and 5 mM sodium phosphate
buffer were used as the negative control. The hydrolyzed form of SAME was used as the
positive control (strong standard). b) With ten participants, olfactory detection of E. coli
at 102 and 104 cfu/mL were compared to the controls of just buffer and NOSE only. The
olfactory signals from the vials which contained 102 and 104 cfu/mL of E. coli are
significantly different from the signal from the NOSE-only vial. Error bars represent the
standard error of means for the measurements. *= p< 0.05, ***=p<0.001.
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We next used headspace gas chromatography to quantify the production of
scent by our bacterial sensor. The concentration of the volatile product present in
the headspace of the sample vial was quantified according to an external
calibration curve (see Supporting Information).

As shown in Figure 4, the

uninhibited lipase cleaves significantly more pro-fragrance than the NOSE and
controls. The control samples of the highest bacteria concentration tested with the
pro-fragrance molecule and the sensor without bacteria did not produce a signal.
The NOSE in the presence of 104 and 106 cfu/mL of E. coli showed a measureable
signal that was significantly different. However, 102 cfu/mL of E. coli did not
produce a detectable signal under the conditions tested. We hypothesize this
discrepancy with the human studies to be a result of the complexities of human
olfactory system.

Figure 4.5: Calibration curve used to determine concentration of phenylethyl alcohol
present in headspace of vials. Samples were prepared by diluting phenylethyl alcohol
into 5 mM sodium phosphate buffer. Peak areas were determined using Origin 9.1
software.
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Figure 4.6: Headspace gas chromatography analysis of sensor response to increasing
concentrations of bacteria. Samples were prepared in triplicate. Error bars represent
standard deviations of the measurements. *= p< 0.05, ***=p<0.001.
4.3. Conclusions
In summary, we report the development a supramolecular-based strategy to
perceive molecular interactions with the human olfactory system. As a proof of
concept, our NOSE was shown to be an effective bacterial sensor based on the
selective production of olfactory detectable compounds.

These studies

demonstrated that by controlling the behavior at the molecular level of responsive
nanomaterials we can alter how human beings observe their surroundings in a
manner that is otherwise impossible. We believe this responsive strategy can be
broadly applied to other surface functionalized nanoparticles and enzymes to
generate arrays of reversibly bound enzyme-nanoparticle complexes. Further
expanding this methodology allows the crafting of an almost limitless number of
aroma profiles by using the readily available multitude of fragrance and enzyme
combinations.
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4.4. Experimental Methods
4.4.1. Materials
All reagents/materials were purchased from Fisher Scientific and used as received.
Benzyl functionalized AuNPs were synthesized according to previous reports.24
4.4.2. Synthesis of Pro-fragrance
0.05 g of 4-dimethylaminopyridine and 0.983 g of succinic anhydride were dissolved in
dry dichloromethane.

1 gram of phenylethyl alcohol was added to the reaction. The

reaction was heated and refluxed overnight. Solvent was then removed and the product
was dissolved in a saturated sodium bicarbonate solution. Aqueous layer was extracted
with ethyl acetate. (2x) Aqueous layer was then acidified and extracted with
dichloromethane. (3x) Dichloromethane layers were combined and dried over sodium
sulfate. Solvent was removed and the obtained product was a white crystalline solid.
Yield = 1.655 grams, 91%, m.p. = 68-70 ºC.
4.4.3. Bacteria Growth Conditions
Bacteria were cultured in LB medium at 37 °C and 275 rpm until stationary phase. The
cultures were then harvested by centrifugation and washed with 0.85 % sodium chloride
solution for three times. Concentrations of resuspended bacterial solution were
determined by optical density measured at 600 nm. 5 mM sodium phosphate buffer was
used to make dilutions of bacterial solutions of 108,106, and 104 cfu/mL.
4.4.4. Plate Reader Assay Conditions
Lipase inhibition assay was done at 25 °C with the final concentrations in Costar clear 96
well plate of 15 nM Lipase, 0.6 mM pNPB, and 20, 40, 60, 80, 100, 125, 150 nM benzyl

68

AuNP. Lipase and benzyl AuNP were first incubated for 30 minutes in 96 well plate to
insure their interaction reaches equilibrium, then 10 µL of substrate p-NPB was added
into the well. The activity of lipase was monitored every 30 seconds for a total of 40
minutes time frame at the absorbance of 405 nm.
4.4.5. Human Trial Assays
4.4.5.1. Olfactory Detection of Lipase Activity
Four different solutions were made in 20 mL glass vials with a final volume of 1 mL
each. 5 mM sodium phosphate buffer and 4 mM SAME were used as the negative
controls and the rose scent (2-Phenylethyl ethanol) was used as the positive control, a
strong standard. The activity of lipase was assessed by incubating 100 nM of lipase with
4 mM of SAME for 20 minutes. The participants were asked to smell these samples and
rank them in the order from 1 to 5 with 1 has the lightest smell and 5 has the strongest
smell.
4.4.5.2. Olfactory Detection of E. Coli
The same procedure was followed as above for buffer and sensor samples. For the E.
Coli-containing vials, 100 nM Lipase was incubated with 300 nM Benzyl AuNP for 30
minutes, and then 10 µL of E. Coli was added into each vial so that the final
concentrations of E. Coli in each vial are 102 and 104 cfu/mL.
4.4.6. Gas Chromatography Head-Space Analysis
Headspace phenylethyl alcohol was measured using a gas chromatograph (model GC17A, Shimadzu Co., Tokyo, Japan) equipped with a solid-phase microextraction (SPME)
auto injector (model AOC-5000, Shimadzu Co., Tokyo, Japan). Samples (1 mL) in 20
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mL glass vials capped with aluminum caps with polytetrafluoroethylene (PTFE)/silicone
septa. Samples were prepared using 500 nM lipase, 1.5 µM benzyl AuNP, and 4 mM of
SAME.

A 50/3 μm divinylbenzene (DVB)/carboxen/polydimethylsiloxane (PDMS)

stable flex (SPME) fiber (Supelco Co., Bellefonte, PA) was then inserted into the vial
headspace for 2 min to absorb volatiles. The fiber was transferred to the GC injector port
(250 °C) for 3 min. The injection port was operated in split mode, and the split ratio was
set at 20:1. Volatiles were separated on a fused-silica capillary Equity-1 Supelco column
(30 × 0.25 mm inner diameter × 25 μm) coated with 100% PDMS at an initial oven
temperature of 70 °C to final temperature of 220 °C over 10 min (step rate 15 °C/min). A
flame ionization detector was used at a temperature of 250 °C. Phenylethyl alcohol
concentrations were determined from peak areas using a standard curve made from
dilutions of phenylethyl alcohol in 5 mM sodium phosphate buffer. Each measurement
was performed in triplicate and results were expressed as mean values ± standard
deviation.
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CHAPTER 5
HYBRID ORGANIC-INORGANIC COLLOIDAL COMPOSITE ‘SPONGES’ VIA
INTERNAL CROSSLINKING
5.1. Introduction
Hybrid organic-inorganic nanocomposites have emerged as promising materials
for a variety of applications such as photonic devices,1 proton exchange membranes,2
emulsifiers,3 and encapsulation vehicles.4 The intimate interactions between the organic
and inorganic components on the nanometer scale produce structures that display
improved stability and generate materials with properties not achievable using the
individual components alone.5,6 Modulation of the individual component compositions
prior to composite formation provides further structural versatility arising from the
'bottom-up' assembly process.7,8 Additionally, nanocomposites are readily amenable to
post-functionalization, providing access to highly diverse functional structures on the
nano and micro scales.9,10, 11,12,13
The in situ generation of porous nanocomposites of controlled sizes with
functional payloads, however, remains a challenge.14 Three widely used strategies for the
creation of colloidal nanocomposites are in situ polymerization,15 sol-gel based
approaches,16 and self-assembly.17 Previously, Armes et al. have created interfacially
active nanocomposites through the polymerization of monomer emulsions stabilized with
silica sols.18 van Blaaderen and coworkers developed a generalized method to produce
hybrid colloids through the sol-gel deposition of inorganic precursors onto nanoparticles
with adsorbed poly(vinylpyrrolidone).19 The work of Möhwald and Caruso harnessed the
self-assembly of polystyrene beads with silica nanoparticles to form composite
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structures.20

Pickering emulsions can also be used as self-assembled templates to

generate complex functional materials.21,22,23

These hybrid systems, however, are

generally used to form core/shell structures as opposed to solid nanocomposite structures.
Herein, we describe a supramolecular/covalent strategy for the generation of
hybrid organic-inorganic composites (Figure 5.1). In this process, hydrophilic aminefunctionalized silica nanoparticles are assembled at the oil/water interface. Reaction of
the particles with a hydrophobic copolymer increases the hydrophobicity of the particles,
resulting in particle migration into the oil phase and confining the covalent bond
formation to the interior of the emulsions. These covalent linkages between nanoparticles
and polymers induces a change in configuration from a reservoir system to a network
composite while preserving the discrete microparticle morphology generated by the
emulsion process. These organic/inorganic hybrid systems are very robust, and show
substantial retention of encapsulated hydrophobic payloads in the presence of ethanol
without the need for post-functionalization or annealing after assembly. Furthermore, the
use of non-toxic maleic anhydride-based polymers24 facilitates the potential use of these
robust systems for a variety of medical and personal care applications.
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Figure 5.1: Schematic depiction of the method used to generate the crosslinked
composites. Water-soluble silica nanoparticles go to the oil/water interface to generate
particle-stabilized Pickering emulsions. The dissolved polymer in the oil phase reacts
with the nanoparticles from the inside of the emulsion via a ring-opening reaction. The
crosslinking reaction simultaneously pulls the nanoparticles into the oil phase as the
nanoparticle surface becomes more hydrophobic, generating an oil-containing composite
structure.
5.2. Results and Discussion
5.2.1. Formulation of hybrid inorganic-organic nanocomposites
Emulsions were generated according to the route depicted in Figure 5.1. Briefly,
the hydrophobic polymer was dissolved in the oil prior to emulsification, with limonene
used as a model hydrophobic oil. Concurrently, silica nanoparticles were suspended in
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Milli-Q water and the solution was adjusted to a pH of 10 with sodium hydroxide to
deprotonate the surface amines and promote covalent attachment to the polymer.25 The
oil phase was added to the aqueous phase and homogenized at 24,000 rpm for two
minutes. Homogenization speeds lower than 24,000 rpm produced larger emulsions with
higher degrees of polydispersity (Figure 5.2). Stable emulsions could be formed at silica
loadings ranging from 0.6 to 2.0 wt % (Figure 5.3, 5.4, 5.5). Polymer loading into the oil
phase did not appear to alter the emulsion morphology or size (Figure 5.6). Emulsions
were then allowed to crosslink overnight at room temperature.
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Figure 5.2: Photograph and bright field microscopy images of composites generated
using different homogenization speeds. Composites were generated by emulsifying 2 mL
of 5 wt % p-MA-alt-1-OD in limonene into 8 mL of 1.5 wt % silica nanoparticles in
Milli-Q adjusted to pH 10 for 2 minutes. Homogenization speeds lower than 24,000 rpm
resulted in larger emulsions with more polydispersity.
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Figure 5.3: Image of composites after one week of storage. Composites were generated
by emulsifying 2 mL of varying wt % p-MA-alt-1-OD in limonene into 8 mL of 0.6 wt %
silica nanoparticles in Milli-Q adjusted to pH 10 for 2 minutes at 24,000 RPM.

Figure 5.4: Image of composites after one week of storage. Composites were generated
by emulsifying 2 mL of varying wt % p-MA-alt-1-OD in limonene into 8 mL of 1.2 wt %
silica nanoparticles in Milli-Q adjusted to pH 10 for 2 minutes at 24,000 RPM.
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Figure 5.5: Image of composites after one week of storage. Composites were generated
by emulsifying 2 mL of varying wt % p-MA-alt-1-OD in limonene into 8 mL of 2.0 wt %
silica nanoparticles in Milli-Q adjusted to pH 10 for 2 minutes at 24,000 RPM.

Figure 5.6: Bright field microscopy images of composites generated with increasing
polymer loadings in the oil phase. Composites were generated by emulsifying 2 mL of
varying wt % p-MA-alt-1-OD in limonene into 8 mL of 1.5 wt % silica nanoparticles in
Milli-Q adjusted to pH 10 for 2 minutes at 24,000 RPM.
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5.2.2. Composite characterization
Confocal microscopy was used to probe the structure of the particle-stabilized
emulsion droplets and visualize the assembly of nanoparticles at the oil/water interface.
Amine-functionalized

silica

nanoparticles

with

cores

containing

fluorescein

isothiocyanate (FITC) were used to track the location of the silica nanoparticles. An
aqueous dispersion of these nanoparticles was emulsified with the organic phase
comprising limonene,

hydrophobic Nile Red dye and p-MA-alt-1-OD crosslinking

polymer. Figure 5.7a-d shows the co-distribution of the nanoparticles and the Nile Red
containing oil phase, suggesting this system does not have the typical core shell structure
of a Pickering emulsion. The average size of the generated composites (2 mL of 5 wt %
p-MA-alt-1-OD in Nile Red loaded limonene: 8 mL of 1.5 wt % silica nanoparticles in
Milli-Q adjusted to pH 10) was 4.2 ± 1.2 µm as determined using microscopy image
analysis. As shown in Figure 5.7e, control studies performed without the crosslinking
polymer in the oil phase formed structures with a core-shell morphology.
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Figure 5.7: Confocal images of FITC-labeled nanoparticles with Nile Red loaded oil
phase. a) The green fluorescence channel shows the FITC-labeled silica nanoparticles
are present at the surface and in the core of the composite. b) Bright field image of the
composite. Inset shows composite size distribution. c) Red fluorescence channel shows
the Nile Red-loadedorganic phase containing limonene and crosslinking polymer p-MAalt-1-OD . d) The merged fluorescence image provides an overlay of the co-localized
green fluorescent nanoparticles with the red fluorescent oil core. e) Merged fluorescence
image of uncrosslinked Pickering emulsions, showing core-shell morphology.
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The colocalization of the hydrophobic dye and nanoparticle fluorescence signals
in Figure 5.7d suggested that structures distinct from core-shell Pickering emulsions were
produced during the crosslinking step. Further demonstration of this morphological
transition was provided using Z-stacked confocal microscopy (Figure 5.8) and optically
cross-sectioning crosslinked microparticles immobilized in an agar medium. The polymer
crosslinked structures displayed a 3D composite structure consistent with the images in
Figure 5.7, where the nanoparticles (green) and Nile red containing oil are co-distributed
throughout the composite as confirmed by the sequential series of optical slices in Figure
5.8.

Figure 5.8: Confocal microscopy cross-sections of a composite structure. Images were
taken in 1 µm slices. Green fluorescence from the nanoparticles and red fluorescence
from the Nile red was colocalized in the oil core of the composite.
Scanning electron microscopy (SEM) and transmission electron microscopy
(TEM) were used to further study the structure of the composite and the morphological
stability of these crosslinked composites under drying conditions.
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SEM of the

crosslinked composites (2 mL 5 wt % p-MA-alt-1-OD in Limonene: 8 mL 1.5 wt % silica
nanoparticles in Milli-Q water) dried from aqueous solution show silica nanoparticles
densely packed into spherical structures (Figure 5.9a, b, Figure 5.10). TEM images show
intact spheres that are in agreement with SEM results (Figure 5.9c, d).

Figure 5.9: a,b) SEM images show densely packed silica nanoparticle and polymer
composites. c,d) TEM images of dried composites show intact spheres, studded with
silica nanoparticles. Composites were formed by emulsifying 2 mL of 5 wt % p-MA-alt1-OD in limonene into 8 mL of 1.5 wt % silica nanoparticles in Milli-Q water.
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Figure 5.10: Scanning electron microscopy image of dried composite structure. Inset
displays composite size distribution. Composites have an average diameter of 2.3 ± 0.72
µm. Composites were generated by emulsifying 2 mL of 5 wt % p-MA-alt-1-OD in
limonene into 8 mL of 1.5 wt % silica nanoparticles in Milli-Q adjusted to pH 10 for 2
minutes at 24,000 RPM.
Having established the morphology of the composites, we next focused on
characterizing the chemical processes involved in the crosslinking step. Infrared
attenuated total reflectance Fourier transform (ATR-FT-IR) spectroscopy was performed
on the amine-functionalized silica nanoparticles, p-MA-alt-1-OD, and the crosslinked
composites (2 mL of 12 wt % p-MA-alt-1-OD in limonene: 8 mL of 1.5 wt % silica
nanoparticles in Milli-Q adjusted to pH 10) to confirm crosslinking between the
nanoparticles and the polymer backbone (Figure 5.11). The crosslinked composites
displayed spectra in agreement with the absorbance spectra shown by both the
nanoparticles and polymer individually. The composites, however, showed a loss of the
maleic anhydride peak and the formation of an absorbance at 1712 cm-1 attributed to the
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carboxylic acid functionality arising from the ring opening of the maleic anhydride.
Broad absorption around 2500 - 3250 cm-1 likewise supports formation of a carboxylic
acid functional group.

Figure 5.11: ATR-FT-IR characterization of the silica nanoparticles, p-MA-alt-1-OD,
and crosslinked composites after composite formation and freeze-drying. Amine
functionalized silica nanoparticles show characteristic peaks at 3280 cm-1, 1063 cm-1, and
936 cm-1 attributed to the Si-O and Si-OH frequencies. Maleic anhydride frequencies at
1856 cm-1 and 1774 cm-1 were identified in the polymer along with the octadecane at
2920 cm-1 and 2851 cm-1. The crosslinked composites possessed peaks at frequencies
similar to both the nanoparticles and polymer. The ring opening of the maleic anhydride
in the polymer was confirmed by the appearance of a peak 1712 cm-1 and the loss of the
peak at 1856 cm-1. Broad absorption around 2500 - 3250 cm-1 is attributed to the
presence of the generated carboxylic acid functionality.
Further characterization of the crosslinking reaction was done by measuring the
amount of remaining free amines on the surface of the nanoparticles after crosslinking.28
The quantification was done through a modified ninhydrin reaction and the external
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calibration curve shown in Figure 5.12. The emulsions were generated through the
emulsification of dichloromethane (to allow easy separation from the aqueous phase)
with increasing amounts of dissolved polymer. The emulsions were reacted overnight to
ensure the ring opening reaction had gone to completion. As shown in Figure 5.13, the
amount of free amines decreases rapidly with increasing polymer concentrations,
showing an almost complete reaction of the amines at higher polymer ratios. Aminefunctionalized silica nanoparticles show 4 amines per square nanometer, in agreement
with literature findings.28 As the amine functionalities present on the surface of the
nanoparticles react with the polymer, the colorimetric reaction with ninhydrin is reduced.
The amine groups are nearly fully crosslinked by 18 wt % p-MA-alt-1-OD in the oil
phase, with a greater extent of crosslinking corresponding to a lower particle loading.

Figure 5.12: Calibration curve used to quantify amines was generated using
3-aminopropyltriethoxysilane (APS) and ninhydrin.
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Figure 5.13: Remaining free amine concentration determined using a modified ninhydrin
reaction with 2 silica loadings as a function of crosslinking polymer concentration. a)
Amine-functionalized silica nanoparticles show 4 amines/nm2 are available for
crosslinking, and amines are readily crosslinked by the polymer with near complete
consumption of the functional groups by 18 wt % p-MA-alt-1-OD. b) Expanded view of
the near complete loss of amine functionality as polymer concentration increases.
The extent of the crosslinking reaction was also examined as a function of pH
(Figure 5.14, 5.15, 5.16). We hypothesized that an increase in maleic anhydride units
within the oil would form more carboxylic acid units and decrease the pH of the system.
To test this hypothesis, the polymer concentration in the oil phase was increased with the
amount of silica held constant and the pH of the emulsified mixture was then monitored
over time. As expected, an increase in polymer concentration induces the pH of the total
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system to lower. The greatest degree of pH change was observed for the highest polymer
loading of 15 wt % p-MA-alt-1-OD in the limonene oil phase with the pH after
emulsification being reduced from 8.5 to 5.5.

Taken together, the IR results, the

ninhydrin assay, and the generation of acid all support amine-anhydride crosslinking
between the particles and polymer.

Figure 5.14: Tracking crosslinking kinetics by monitoring the decrease in pH due to
formation of carboxylic acid groups during crosslinking of amine-functionalized silica
nanoparticles by p-MA-alt-1-OD polymer in the oil phase. An increase in polymer
concentration resulted in an appreciably lower pH once equilibrium was established,
indicating that pH is a sensitive probe for reaction kinetics.
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Figure 5.15: Plot of the decrease in pH over time with varying amounts p-MA-alt-1-OD
in limonene. Composites were generated by emulsifying 2 mL of varying wt % p-MAalt-1-OD in limonene into 8 mL of 0.5 wt % silica nanoparticles in Milli-Q adjusted to
pH 10 for 2 minutes at 24,000 RPM. The reactions were measured by immersing a pH
probe into the solution following emulsification.
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Figure 5.16: Plot of the decrease in pH over time with varying amounts p-MA-alt-1-OD
in limonene. Composites were generated by emulsifying 2 mL of varying wt % p-MAalt-1-OD in limonene into 8 mL of 1.0 wt % silica nanoparticles in Milli-Q adjusted to
pH 10 for 2 minutes at 24,000 RPM. The reactions were measured by immersing a pH
probe into the solution following emulsification.
5.2.3. Stability of Composites
To determine robustness and durability, the crosslinked composites were stored
for one month. Figure 5.17a shows the composites prior to storage. After storage for one
month, the composites do not undergo visible phase separation, indicating effective
entrapment of the oil within the hybrid matrix. Additionally, the average size of the
composites does not change significantly as shown in Figure 5.17b, though some change
in distribution is observed. Although the composites creamed over time, this is attributed
to the lower density, 0.8411 g/mL, of the limonene core compared to the continuous
aqueous phase and is not indicative of leakage or instability (Figure 5.18). Polymer
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loading did not significantly alter the particle size distributions of the resulting
assemblies.

Figure 5.17: a) Bright field image of composites prior to storage. Inset shows distribution
of composite sizes determined by image analysis. Composites had an average diameter
of 4.2 ± 1.2 µm. b) Bright field image of composites after one month of storage. Inset
shows distribution of composite size. Composites had an average diameter of 4.5 ± 1.5
µm.
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Figure 5.18: Image of the composites with varying wt. % of polymer dissolved in the
limonene phase after one month of storage. Composites were generated by emulsifying 2
mL of varying wt % p-MA-alt-1-OD in limonene into 8 mL of 1.5 wt % silica
nanoparticles in Milli-Q adjusted to pH 10 for 2 minutes at 24,000 RPM. Composite
were sealed and stored for one month at room temperature.
5.2.4. Payload release by the crosslinked composites
Based on the structural studies above, we postulated that these materials should
behave as porous 'sponges', retaining payload in competitive environments without
dissociating. To test this possibility, we explored the release of payload from the
nanocomposites in ethanol, using diphenyl ether as a tracer molecule. Diphenyl ether
was chosen as an appropriate tracer due to its closely matching logP value of 4.21
compared to 4.23 for limonene. The addition of diphenyl ether (13 wt %) to the limonene
did not affect the overall structure of the composite as determined by optical microscopy
(Figure 5.19). There was no change in composite size upon incubation with ethanol as
observed by optical microscopy, demonstrating the stability of these systems in an
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environment of intermediate polarity (Figure 5.20). To quantify the leaching of payload
in a model competitive medium, the composites were incubated for one hour in absolute
ethanol. The composites were subsequently centrifuged and the UV-absorbance spectra
of the supernatant was recorded to quantify release. As expected, an increase in polymer
concentration increases the crosslinking density thereby reducing oil release, with
capsules containing 5 wt % of polymer in the oil phase displaying maximum payload
retention (Figure 5.21).

At higher polymer concentrations, there was no additional

payload retention, consistent with the complete reaction of the surface amines found in
the ninhydrin assay. These results further support the hypothesis that the increasing
number of covalent nanoparticle-polymer bonds reduces the permeability through the
composite matrix.
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Figure 5.19: Bright field microscopy images of composites generated with increasing
polymer loadings in the oil phase used for release quantification. Composites were
generated by emulsifying 2 mL of varying wt % p-MA-alt-1-OD in a 13 % v/v mixture of
diphenyl ether in limonene into 8 mL of 1.5 wt % silica nanoparticles in Milli-Q adjusted
to pH 10 for 2 minutes at 24,000 RPM.
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Figure 5.20: Bright field image of composites incubated with ethanol. Inset displays
composite size distribution. Composites had an average diameter of 4.4 ± 0.9 µm.
Composites were generated by emulsifying 2 mL of 5 wt % p-MA-alt-1-OD in a 13 %
v/v mixture of diphenyl ether in limonene into 8 mL of 1.5 wt % silica nanoparticles in
Milli-Q adjusted to pH 10 for 2 minutes at 24,000 RPM.
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Figure 5.21: Release of diphenyl ether tracer from composites as a function of wt. %
polymer dissolved in the limonene oil phase. Greater tracer retention was achieved by
higher polymer loadings. The control capsules generated with the individual components
showed complete release of payload. The curve was drawn to assist the eye.
5.3. Conclusions
We have shown that amine functionalized silica nanoparticles and maleic
anhydride copolymers form stable size-controlled organic-inorganic hybrid composites
from an oil/water emulsion template. Due to the alternating structure of the hydrophobic
polymer used for the crosslinking, we hypothesize that this inside-out crosslinking
method

extensively

connects

the

nanoparticles

and

alters

the

nanoparticles

hydrophobicity at the oil/water interface, with the nanoparticles pulled into the oil core as
their surfaces become more hydrophobic. These hybrid composites showed considerable
resistance to the generally interface disrupting influence of ethanol. Future experiments
will explore tuning the porosity of the structure through modification of the component
precursors. The ability to parametrically vary the polymeric and inorganic components to
tune the release behavior without greatly altering the vehicle’s size is a particular
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advantage over other porous delivery vehicles. These systems will also be probed for
their effectiveness in multicomponent fragrance formulations and their ability to
incorporate biomolecules into the composite structure for delivery and catalytic
applications. Moreover, this Pickering emulsion-based strategy provides a potentially
generalizable strategy to generate in situ reservoirs of hydrophobic molecules for
multiple controlled release and delivery applications.
5.4. Experimental Methods
5.4.1. Materials
Tetraethyl orthosilicate (purity of 99%), 3-aminopropyl triethoxysilane (purity of 99%),
ammonium hydroxide (28% ACS Plus), sodium hydroxide (purity of 97%), Nile Red
(purity of 99%), fluorescein isothiocyanate isomer I (purity of 90%), agar (granulated,
Fisher BioReagentsTM), diphenyl ether (purity of 99%), and 200 proof ethanol were
purchased from Fisher Scientific and used as received. Poly(maleic anhydride-alt-1octadecene) (p-MA-alt-1-OD; average Mn of 30,000-50,000) was purchased from SigmaAldrich and used as received. Limonene was provided by Firmenich Inc. Milli-Q water
with a resistivity of 18.2 MΩ∙cm was used for all experiments.
5.4.2. Synthesis and Functionalization of Silica Nanoparticles
The silica nanoparticles were synthesized using an adapted Stober method.26 Briefly, to
synthesize 150 nm amine functionalized silica nanoparticles, 24 mL of ammonium
hydroxide were added to 300 mL of absolute ethanol and stirred for five minutes in a 500
mL round-bottom flask. Then 12 mL of tetraethyl orthosilicate were added to the reaction
flask and stirred overnight at room temperature. To functionalize the surface of the
nanoparticles, 1.22 mL of 3-aminopropyl triethoxysilane were added and the reaction was
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stirred for an additional 24 hours. The nanoparticles were purified by centrifuging and redispersing in water and ethanol (3x each). The washed silica nanoparticles were
lyophilized and used in powdered form. The nanoparticles had an average diameter of
150 ± 13 nm determined by transmission electron microscopy (TEM) and 165.1 ± 3.5 nm
determined by dynamic light scattering (DLS), (Figure 5.22, 5.23). The nanoparticles had
a zeta potential of +16.3 ± 3.6 mV in 5 mM sodium phosphate buffer (pH = 7.4), (Figure
5.24). Synthesis of fluorescein labeled nanoparticles27 was performed following a similar
method wherein 5.25 mg of fluorescein isothiocyanate were reacted with 69.0 mg of 3aminopropyl triethoxysilane in one mL of absolute ethanol under nitrogen overnight. This
fluorescent conjugate mixture was added to the nanoparticle reaction solution 5 minutes
after the addition of tetraethyl orthosilicate. The procedure then proceeded as described
above.
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Figure 5.22: Transmission electron microscopy image of silica nanoparticles used
throughout the study. Nanoparticles had an average diameter of 154 ± 13 nm.

Figure 5.23: Average diameter by number of silica nanoparticles in MilliQ water as
determined by dynamic light scattering was 165.1 ± 3.5 nm.

Figure 5.24: The average zeta potential of the silica nanoparticles was 16.3 ± 3.64 mV in
5 mM phosphate buffer adjusted to pH 7.4.
5.4.3. Microscopy and Particle Characterization
TEM samples were prepared on 300 square mesh nickel grids with Formvar film
purchased from Electron Microscopy Sciences. TEM images were acquired on a JEOL
100CX operating at 100 keV. Scanning electron microscopy (SEM) data were obtained
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using a FEI Magellan 400 field emission scanning electron microscope operated at 1.0
kV with 13 µA of beam current. Samples were prepared by drying diluted sample onto a
boron-doped Si wafer purchased from WRS Materials. DLS data were measured with a
Malvern Zetasizer Nano ZS. Optical and fluorescence images of the capsules were taken
on an Olympus IX51 microscope. Confocal experiments were performed on a Zeiss
LSM510 meta confocal microscope. Nile Red, a lipophilic fluorophore, was loaded into
the oil phase at 0.05 wt. % to facilitate fluorescence microscopy. For the z-stack images
the capsules were diluted into a 0.5 % w/w agar in water solution to reduce the Brownian
motion of the matrix microparticles. ImageJ software was used to determine average
diameters of composites for all microscopy methods.
5.4.4. Emulsification
Emulsions were generated using an IKA T 25 digital ultra-turrax disperser with an S25N10G dispersing element. The 20 % v/v oil in water emulsions were made by emulsifying
2 mL of hydrophobic oil containing the hydrophobic polymer into 8 mL of pH 10
adjusted water with dispersed 150 nm amine functionalized silica nanoparticles at a
homogenization speed of 24,000 RPM for two minutes. The as-formed emulsions were
allowed to react for one day before characterization.
The formulation used for characterization unless otherwise specified was 2 mL of 5 wt %
p-MA-alt-1-OD in limonene emulsified into 8 mL of 1.5 wt % silica nanoparticle solution
in Milli-Q adjusted to pH 10.
5.4.5. ATR-FT-IR of Silica Nanoparticles, Polymer, and Freeze-dried Crosslinked
Composite
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IR was performed on a Bruker Alpha FT-IR spectrophotometer fitted with a Platinum
ATR QuickSnap sampling module. The silica nanoparticles and polymer were analyzed
as neat solids. The crosslinked composites were freeze-dried in order to obtain a dry solid
that was analyzed in the same fashion.
5.4.6. Ninhydrin Assay for Amine Quantification
One mL of the crosslinked nanoparticle-stabilized composite solution was added to one
mL of the generated stock ninhydrin solution (0.35 w/v % in pure ethanol) in a 7 mL
glass vial and sealed. The vial was heated for 60 seconds; thereafter a blue/purple color
was obtained. The vial was centrifuged at 14,000 rpm for 20 minutes, the supernatant was
transferred to a cuvette, and the absorbance at 588 nm was recorded. This absorbance was
compared to a generated calibration curve using 3-aminopropyl triethoxysilane and
ninhydrin to determine the amount of free amine.28
5.4.7. Release Studies
Diphenyl ether was selected to be a tracer within the limonene core. The hydrophobic oil
comprised 13 wt. % of diphenyl ether in limonene, and emulsions were formed in the
same fashion as previously described. After the emulsions were allowed to react for one
day, 100 µL of the emulsion slurry were incubated in 4 mL of absolute ethanol for one
hour. The absorbance of the solution at 270 nm (the observed maximum absorbance of
diphenyl ether) was recorded. A calibration curve was generated and used to determine
the amount of diphenyl ether released into the ethanol.
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CHAPTER 6
NANOPARTICLE STABILIZED CAPSULES FOR THE TREATMENT OF
BACTERIAL BIOFILMS
6.1. Introduction
Bacterial biofilms are highly resilient microbial assemblies that are difficult to
eradicate.1 These robust biofilms frequently occur on synthetic implants and indwelling
medical devices including urinary catheters,2 arthro-prostheses,3 and dental implants.4
Biofilm proliferation can also occur on dead or living tissues, leading to endocarditis,5
otitis media,6 and chronic wounds.7 The persistent infections and their concomitant
diseases are challenging to treat, as biofilms develop a high resistance to host immune
responses and the extracellular polymeric substances limit antibiotic penetration into
biofilms.8,9

Current techniques to remove biofilms on man-made surfaces include

disinfecting the surface with bleach or other caustic agents.10 Biofilms in biomedical
contexts are very challenging, with therapies based on excising infected tissues combined
with long-term antibiotic therapy, incurring high health care costs and low patient
compliance due to the invasive treatment.11 This issue is exacerbated by the exponential
rise in antibiotic resistant bacteria.12
Phytochemicals have emerged as an promising alternative to traditional
antimicrobials to treat antibiotic resistant bacteria.13,14 These essential oils and natural
compounds are of particular interest as “green” antimicrobial agents due to their lowcost, biocompatibility, and potential anti-biofilm properties.15,16,17 The generally poor
aqueous solubility and stability of these oils has substantially limited their widespread
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application.18

Engineering nanomaterials provides a potential platform to prevent

payload degradation and to tune molecular interactions with bacteria. 19,20,21,22 Previous
reports have shown that encapsulating essential oils into surfactant-stabilized colloidal
delivery vehicles improves their aqueous stability and increases the antimicrobial activity
of small molecule payloads.23,24,25

However, these carriers often induce adverse

hemolytic or irritating effects restricting their compatibility with biological tissues.26,27
Pickering emulsions provide an analogous route to encapsulate hydrophobic molecules
within a self-assembled colloidal shell that is highly resistant to coalescence.28,29

The

multivalent nanoparticles embedded at the oil/water interface can also be postfunctionalized to create structurally diverse carriers not achievable when using surfactant
stabilized emulsions.30,31
Herein, we describe the fabrication of a multifunctional essential oil-based
Pickering emulsion for the treatment of bacterial biofilms. The self-assembly strategy
relies on hydrophobic phytochemicals playing both antimicrobial and structural roles for
the drug delivery vehicle. Peppermint oil droplets provide the main hydrophobic core
template for nanoparticle assembly. Dissolved cinnamaldehyde plays a dual role within
the oil core by covalently reacting with the nanoparticles at the interface to modify the
shell of the capsules from within and acting as a potent antimicrobial agent once
delivered into the biofilm. These microcapsules effectively eradicate both laboratory and
pathogenic biofilms.

The inclusion of cinnamaldehyde also enhanced fibroblast

proliferation32 promoting therapeutic behavior of the capsules as demonstrated in an in
vitro co-culture model. This work presents a versatile colloidal strategy for
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multicomponent essential oil formulations with potential use as a general topical
antimicrobial and disinfectant.
6.2. Results and Discussion
6.2.1. Generation and characterization of capsules
Silica nanoparticles (SiO2 NPs) were chosen to stabilize the emulsions as they are
biocompatible, surface functionalization can be easily introduced, and their diameters can
be readily tuned.31,33,34 Control over the size is especially important as nanomaterials
smaller than 70 nm have been shown to readily penetrate the skin causing detrimental
side-effects.35,36,37 Therefore, we synthesized cationic amine-functionalized SiO2 NPs
with an average diameter of ~150 nm. (Figure 6.1, 6.2, 6.3) Antimicrobial capsules were
generated using a Pickering emulsion template as shown in Figure 6.4. Capsules were
created by emulsifying either peppermint oil or a mixture of cinnamaldehyde dissolved in
peppermint oil into MilliQ H2O adjusted to a pH of 10 containing the nanoparticles. The
nanoparticles self-assemble at the oil/water interface to stabilize the peppermint oil
droplets. Surface amines on the nanoparticles then react with the cinnamaldehyde within
the oil phase. Silica loadings in the aqueous phase were varied to determine the amount
needed to minimize capsule dispersity. At loadings above of 1.2 wt. % SiO2 NPs or
greater, capsules were found to have a minimum dispersity and therefore this amount was
chosen for all further studies. (Figure 6.5) It was also observed that capsules generated
with higher than 5 % v/v cinnamaldehyde were unstable which corresponds to 52-fold
excess of cinnamaldehyde to available amines on the nanoparticle surface. (Figure 6.6)
These peppermint oil based capsules (P-Cap) and capsules containing 5 % v/v of
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cinnamaldehyde dissolved in peppermint oil (CP-Cap) were found to have average
diameters of 6.8 ± 1.9 µm and 6.7 ± 1.9 µm, respectively. (Figure 6.7)

Figure 6.1: Transmission electron microscopy (TEM) image of silica nanoparticles. The
nanoparticles had an average diameter of 152 ± 15 nm. Inset is a histogram of the
measured nanoparticle diameters. Scale bar is 500 nm.
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Figure 6.2: Average diameter of the silica nanoparticles in MilliQ H2O was determined to
be 171.5 ± 2.8 nm by dynamic light scattering (DLS).

Figure 6.3: Zeta potential of the silica nanoparticles in 5 mM sodium phosphate buffer
adjusted to pH 7.4 was found to be 16.7 ± 0.1 mV.

108

Figure 6.4: a) Schematic depiction of the strategy used to generate antimicrobial capsules.
Peppermint oil with dissolved cinnamaldehyde is emulsified into an aqueous suspension
of amine functionalized silica nanoparticles. Cinnamaldehyde within the oil reacts with
the amines on the nanoparticles at the oil/water interface to create a multimodal delivery
vehicle. b) Capsules interact with biofilm through electrostatic complementarity.
Capsules release their payload disrupting the biofilm, eliminating the bacteria.
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Figure 6.5: Optical microscopy images of P-Caps with increasing amounts of silica
loading. P-Caps were generated using aqueous phases comprised of a) 0.3 wt. % silica
(average diameter = 6.1 ± 3.0 µm), b) 0.6 wt. % silica (average diameter = 7.1 ± 3.0 µm),
c) 0.9 wt. % silica (average diameter = 6.7 ± 2.1 µm), d) 1.2 wt. % silica (average
diameter = 6.5 ± 1.7 µm), and e) 1.5 wt. % silica (average diameter = 6.6 ± 2.1 µm),
respectively. Insets are histograms of the capsule diameter measurements. Scale bars are
50 µm. f) Box plot of the P-Caps at various silica loadings demonstrating capsule
dispersity minimizes with increasing wt. % of silica.
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Figure 6.6: Capsules generated with increasing concentrations of cinnamaldehyde.
Capsules were generated by adding 300 µL of peppermint oil or a cinnamaldehydepeppermint oil mixture to 1.2 mL of MilliQ H2O adjusted to a pH of 10 containing 1.2
wt. % of silica nanoparticles and emulsifying for 50 seconds.

111

Figure 6.7: Optical microscopy images of a) P-Cap and b) CP-Cap. P-Cap had an
average diameter of 6.8 ± 1.9 µm and CP-Cap had an average diameter of 6.7 ± 1.9 µm.
Insets are histograms of the capsule diameter measurements. Scale bars are 50 µm.
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We used confocal microscopy, X-ray photoelectron spectroscopy (XPS),
attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR), and
contact angle goniometry to probe the cinnamaldehyde-nanoparticle interaction.
Reactive molecules within the oil core of Pickering emulsions have been previously
demonstrated to affect capsule morphologies by modulating the hydrophobicity of the
nanoparticles.38,39 To determine if structural reorganization occurs with our mixed oil
system, capsules were generated using a Nile red loaded oil core and nanoparticles
possessing cores labeled with fluorescein isothiocyanate (FITC). As shown in Figure
6.8a, b, and Figure 6.9, both capsules with and without cinnamaldehyde possess coreshell morphologies. This result indicates that the 5 % v/v loading of cinnamaldehyde into
the peppermint oil does not alter the capsule structure.
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Figure 6.8: Confocal micrographs of a) P-Cap and b) CP-Cap. The nanoparticles’ cores
are labeled with fluorescein (green fluorescence) and the oil phases are loaded with Nile
red (red fluorescence). Scale bars are 20 μm. c) XPS spectra showing N 1s core levels
arising from SiO2 NPs and CP-Cap. d) Water contact angles of silica nanoparticles
following incubation with varying concentrations of cinnamaldehyde.
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Figure 6.9: Confocal microscopy images of a) P-Cap and b) CP-Cap. The nanoparticles’
cores are labeled with fluorescein (green fluorescence) and the oil phases are loaded with
Nile red (red fluorescence). Scale bars are 10 μm.
We next used XPS and ATR-FTIR to elucidate the reactivity of the nanoparticles
with the dissolved cinnamaldehyde of the capsules. Prior to analysis, CP-Caps were
disrupted with ethanol, centrifuged, and lyophilized to remove any adsorbed
cinnamaldehyde. The Schiff base of 3-aminopropyltriethoxysilane and cinnamaldehyde
was also synthesized for comparison. (Figure 6.10) As shown in Figure 6.8c, the SiO2
NPs showed two chemically distinct species with a lower binding energy (BE)
component at ca. 399.5 eV and a higher BE component at ca. 401.8 eV.

These

correspond to amine (-NH-) and protonated amine (NH3+) present on the surface of SiO2
NPs that is consistent with previously reported values.40 The N 1s spectra of CP-Cap
shows three distinct chemical species. In addition to the two N 1s BE components
observed in the SiO2 NPs, a new peak centered at ca. 400.1 eV indicates the formation of
an imine functional (-C=N-) group which corroborates well with literature values.41 The
N 1s spectra from the synthesized Schiff base showed a single chemically distinct N 1s
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species centered at ca. 400.2 eV, which corresponds to the imine functional group (-C=N).41 Similarly, the chemically distinct species of the C 1s spectra obtained from CP-Cap
matches well with the synthesized Schiff base further providing evidence on the covalent
linkage of the amine and cinnamaldehyde (Figure 6.11). Additionally, the Si 2p and O 1s
peak shows typical BEs centered at ca. 103.2 eV and 532.6 eV, respectively that matches
with reported values for SiO2 NPs (Figure 6.11).42 ATR-FTIR analysis further supported
the formation of the cinnamaldehyde Schiff base (Figure 6.12).

Figure 6.10: 400 MHz 1H NMR spectrum of the Schiff base, 3-phenyl-N-(3triethoxysilylpropyl)prop-2-en-1-imine, in chloroform-D (D-99.8 %). Spectrum was
obtained on a Bruker Avance 400 MHz, 16 scans.
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Figure 6.11: XPS spectra of a) amine functionalized SiO2 NPs, b) CP-Caps, and c) Schiff
base.
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Figure 6.12: ATR-FT-IR characterization of cinnamaldehyde, the cinnamaldehyde-silane
Schiff base, the silica nanoparticles, and CP-Caps after freeze drying. Cinnamaldehyde
displayed characteristic peaks at 1667 cm−1 and 1624 cm−1 attributed to the C=O and
C=C frequencies. The Schiff base possessed peaks at 1681 cm−1 and 1633 cm−1
attributed to C=N and C=C bonds, respectively. The Schiff base also displayed peaks at
1102 cm−1 and 1006 cm−1 attributed to the Si-O and Si-OEt frequencies. Aminefunctionalized silica nanoparticles showed characteristic peaks at 1080 cm−1 and 947
cm−1 attributed to the Si-O and Si-OH frequencies. CP-Caps displayed peaks at
frequencies similar to the SiO2 NPs and the Schiff base confirming the formation of the
Schiff base complex on the nanoparticles.
An in situ covalent reaction of the primary amine groups on the nanoparticles
with cinnamaldehyde should alter the hydrophobicity of the nanoparticle surface
improving the stabilization behavior of the Pickering emulsifiers. 43

Contact angle

goniometry was used to measure the change in nanoparticle hydrophobicity.
Nanoparticles were deposited onto silicon wafers and briefly incubated in
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dichloromethane solutions with varying amounts of dissolved cinnamaldehyde. The
surfaces were then rinsed with dichloromethane, dried, and the water contact angles were
obtained. (Figure 6.13) Figure 6.8d shows that as the percentage of cinnamaldehyde by
volume increases from 0 % to 5 %, the water contact angle of the nanoparticles increases
from 31° to 49°. This increase in water contact angle, taken together with the XPS data,
the ATR-FTIR data, and confocal images, indicates that the inclusion of cinnamaldehyde
within the peppermint oil core generates a distinct, multi-component capsule structure.

Figure 6.13: Representative digital images of water droplets used to determine contact
angles.

6.2.2. Capsule penetration into the biofilms
Biofilms produce extracellular polymeric substances that prevent effective
delivery of therapeutics.44

Having established that the capsules have core-shell

morphologies and the cinnamaldehyde is successfully incorporated into the capsules, we
set out to determine whether these capsules could effectively penetrate into biofilms.
Using fluorescently labeled nanoparticles to track the delivery of the emulsions, we
treated biofilms from E. coli that had been modified to express E2-Crimson, a far-red
fluorescent protein. As shown in Figure 6.14, both P-Cap and CP-Cap diffuse into the
biofilm matrix and efficiently disperse throughout the biofilm whereas the unassembled
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nanoparticles displayed minimal penetration. These data indicate the capsules deliver
their payload in a burst release fashion and that both the oil core and nanoparticle shell
are operative for effective delivery.

Figure 6.14: Representative 3D projection of confocal image stacks of 1 day-old E. coli
DH5α biofilm after 3 hrs treatment with a) CP-Cap containing FITC-labeled SiO2 NP, b)
P-Cap containing FITC-labeled SiO2 NP, and c) FITC-labeled SiO2 NP at 20 % (v/v %
of 2 % emulsion) concentration. Upper panels are projection at 247° angle turning along
Y axis and lower panels are at 270° angle turning along Y axis. Scale bars are 20 μm.
6.2.3. Antimicrobial activity of capsules against biofilms
Next, we investigated the therapeutic behavior of the capsules against established
bacterial biofilms. One laboratory strain, E. coli DH5α, and 3 pathogenic bacteria strains
of clinical isolates, P. aeruginosa (CD-1006), S. aureus (CD-489, a methicillin-resistant
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strain), and E. cloacae complex (CD-1412), were chosen to test our system. As shown in
Figure 6.15, both the CP-Cap and P-Cap vehicles effectively were able to kill bacteria
cells in all four biofilms, with CP-Cap possessing greater activity.

The capsules

demonstrated a dramatically enhanced efficacy compared with the unencapsulated oil,
supporting the hypothesis that the cationic nanoparticle shell of the capsules increases
interaction with the biofilms.45 In addition, the acidic pH of the biofilm environment46
should promote the hydrolysis of Schiff bases, enhancing the sustained release of
cinnamaldehyde. These capsules were able to treat both Gram negative (E. coli, P.
aeruginosa, and E. cloacae complex) and Gram positive (S. aureus) bacteria. Notably,
the capsules demonstrated a similar efficacy against the multi-drug resistant S. aureus
stain when compared to the non-resistant strains, supporting that these capsules present a
viable treatment alternative to traditional antibiotics.
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Figure 6.15: Viability of 1 day-old a) P. aeruginosa (CD-1006) b) E. coli DH5α c) S.
aureus (CD-489) d) E. cloacae complex (CD-1412) biofilms after 3 hrs treatment with
CP-Cap, P-Cap, SiO2 NP, and peppermint oil at different emulsion concentrations (v/v %
of 2 % emulsion). The data are average of triplicates and the error bars indicate the
standard deviations.
6.2.4. Co-culture treatment of biofilms
Biofilm infections within wounds interfere with the ability of the host to
regenerate damaged tissue.47 Fibroblasts in particular play a vital role in the wound
healing process, helping to close the injury and redevelop the extracellular matrix within
the skin.48,49 We used an in vitro co-culture model comprised of mammalian fibroblasts
and a biofilm to determine whether our capsules could successfully treat a biofilm in the
presence of host cells. 50 E. coli DH5α bacteria were seeded with a confluent NIH 3T3
fibroblast cell monolayer overnight to generate biofilms prior to treatment. The co122

cultures were treated with capsules for 3 hrs, washed, and the viabilities of both
fibroblasts and bacteria were measured. As shown in Figure 6.16, CP-Cap effectively
treated the biofilm infection whereas P-Cap and the controls did not.

The capsule

structure also prevented the toxic effects shown by the unencapsulated peppermint oil to
the fibroblasts. Notably, CP-Cap enhanced 3T3 cell growth in agreement with studies
that cinnamaldehyde can promote insulin-like growth factor-I signaling, increasing cell
proliferation.32

Figure 6.16: Viability of 3T3 fibroblast cells and E. coli biofilms in the co-culture model
after 3 hrs treatment with a) CP-Cap, b) P-Cap, c) SiO2 NP, and d) peppermint oil at
different emulsion concentrations (v/v % of 2 % emulsion). Scatters and lines represent
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3T3 fibroblast cell viability. Bars represent log10 of colony forming units in biofilms. The
data are average of triplicates and the error bars indicate the standard deviations.
6.3. Conclusions
In summary, we report the development of a multimodal antimicrobial delivery
vehicle. The nanoparticle stabilized capsules demonstrated highly effective therapeutic
behavior, successfully eradicating pathogenic biofilm strains of clinical isolates.
Furthermore, the capsules effectively eliminated a biofilm infection while promoting
fibroblast viability in an in vitro co-culture model. Future studies will probe capsule
performance in combating in vivo biofilms. These capsules have potential applications
as a general surface disinfectant as well as an antiseptic for wound treatment. The
reactive self-assembly based strategy provides a promising platform to create effective
delivery vehicles to combat bacterial biofilms.
6.4. Experimental Methods
6.4.1. Materials
All reagents/materials were purchased from Fisher Scientific and used as received.
Boron-doped Si wafers were purchased from WRS Materials. NIH-3T3 cells (ATCC
CRL-1658) were purchased from ATCC.

Dulbecco's Modified Eagle's Medium

(DMEM) (DMEM; ATCC 30-2002) and fetal bovine serum (Fisher Scientific,
SH3007103) were used in cell culture.

Pierce LDH Cytotoxicity Assay Kit was

purchased from Fisher Scientific.
6.4.2. Synthesis of Silica Nanoparticles
Silica nanoparticles were synthesized according to the reported procedure.33,38 Briefly, to
synthesize 150 nm amine functionalized silica nanoparticles, 24 mL of ammonium
hydroxide were added to 300 mL of absolute ethanol and stirred for five minutes in a 500
124

mL round-bottom flask. Then 12 mL of tetraethyl orthosilicate were added to the reaction
flask and stirred overnight at room temperature. To functionalize the surface of the
nanoparticles, 1.22 mL of 3-aminopropyl triethoxysilane were added and the reaction was
stirred for an additional 24 hours. The nanoparticles were purified by centrifuging and redispersing in water and ethanol (3x each).
Synthesis of fluorescein labeled nanoparticles51 was performed following a similar
method wherein 5.25 mg of fluorescein isothiocyanate were reacted with 69.0 mg of 3aminopropyl triethoxysilane in one mL of absolute ethanol under nitrogen overnight. This
fluorescent conjugate mixture was added to the nanoparticle reaction solution 5 minutes
after the addition of tetraethyl orthosilicate. The procedure then proceeded as described
above.
6.4.3. Transmission Electron Microscopy (TEM)
TEM samples were prepared on 300 square mesh nickel grids with Formvar film
purchased from Electron Microscopy Sciences. TEM images were acquired on a JEOL
100CX operating at 100 keV.
6.4.4. Dynamic Light Scattering (DLS)
DLS experiments and zeta potential measurements were performed using a Malvern
Zetasizer Nano ZS. Samples were sonicated prior to measurements.
6.4.5. Preparation of Capsules
Stock capsules solutions were prepared in 1.5 mL Eppendorf tubes. To prepare the stock
P-Cap emulsions, 300 µL of peppermint oil was added to 1.2 mL of a 1.2 % wt. solution
of SiO2 NPs in MilliQ H2O adjusted to pH 10 and was emulsified in an amalgamator for
50 seconds. To prepare the stock CP-Cap emulsions, 15 µL of cinnamaldehyde was
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dissolved in 285 µL of peppermint oil prior to emulsification as described.
emulsions were allowed to rest overnight prior to use.

The

Optical images of the capsules

were taken on an Olympus IX51 microscope.
6.4.6. Synthesis of Schiff Base
Cinnamaldehyde (3.8 mL, 30 mmol) was dissolved in 150 mL of toluene and 3aminopropyl triethoxysilane (7.0 mL, 30 mmol) was added to the stirring reaction. The
flask was then equipped with a Dean-Stark trap, heated to 110 °C, and stirred overnight.
After the reaction was complete (monitored by water volume collected in Dean-Stark
trap), the mixture was cooled to room temperature and the solvent removed under
reduced pressure. The crude product was dissolved in dichloromethane and filtered to
remove brown precipitates. The filtrate was dried over anhydrous sodium sulfate and the
dichloromethane was removed under reduced pressure. The product was obtained as an
amber colored oil, yield = 8.78 g, 87 %.
6.4.7. XPS Determination of Cinnamaldehyde Reaction
To determine whether cinnamaldehyde reacted with the surface amines of the
nanoparticle, 500 µL of CP-Cap with 5 % v/v of cinnamaldehyde were diluted into 1.0 ml
of ethanol. Capsules were then broken by sonicating for 5 minutes and centrifuging at
14,000 rpm to release all unreacted cinnamaldehyde.

Capsule were redispersed in

ethanol, sonicated, and centrifuged three times to completely remove the oil phase. The
CP-Cap pellet was then freeze dried in order to obtain a dry solid for analysis.
Samples were prepared by drop-casting the sample on a 100 nm gold-coated silicon
substrate. XPS measurements were carried out using Physical Electronics Quantum 2000
spectrometer at a pressure below 1×10–9 Torr. The survey scan, C 1s, N 1s, O 1s and Si
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2p core level spectra for all samples were recorded with un-monochromatized Al Kα
radiation (photon energy of 1486.6 eV) at a pass energy of 46.95 eV and electron takeoff
angle of 15°. The overall resolution was 0.2 eV for the XPS measurements. Chemically
distinct species were resolved using a Gaussian-Lorentzian function with non-linear leastsquare fitting procedure. All XPS spectra were background corrected using the Shirley
algorithm and aligning the elemental binding energies to the adventitious carbon (C1s)
binding energy of 284.6 eV.42
6.4.8. ATR-FT-IR Determination of Cinnamaldehyde Reaction
IR was performed on a Bruker Alpha FT-IR spectrophotometer fitted with a Platinum
ATR QuickSnap sampling module. Cinnamaldehyde was analyzed as a pure liquid. The
silica nanoparticles and Schiff base were analyzed as neat solids. The CP-Caps were
dissolved in ethanol, sonicated, and centrifuged three times to remove the oil phase. The
CP-Cap pellet was then freeze dried in order to obtain a dry solid that was analyzed.
6.4.9. Contact Angle Goniometry
Samples were prepared by immersing a clean silicon wafer (1 cm x 1 cm) into 1 mL of a
1.2 % wt. solution of SiO2 NPs in MilliQ H2O adjusted to pH 10 for 5 minutes. Wafers
were then washed with MilliQ H2O to removed excess nanoparticles and dried under a N2
stream. Samples were then incubated in 1 mL solutions of dichloromethane with varying
amounts (0, 1, 2, 5 % v/v) of dissolved cinnamaldehyde for 5 minutes. Wafers were then
washed with dichloromethane and dried under a N2 stream. Static water contact angles
were measured using a VCA Optima surface analysis/goniometry system with water
droplets size of 2 µL.
6.4.10. Biofilm Formation
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Biofilms were grown as previously reported.50 Bacteria were inoculated in lysogeny
broth (LB) medium at 37 °C until stationary phase. The cultures were then harvested by
centrifugation and washed with 0.85 % sodium chloride solution three times.
Concentrations of resuspended bacterial solution were determined by optical density
measured at 600 nm. LB medium was supplemented with 0.1 % glucose, 1 mM MgSO4,
0.15 M ammonium sulfate, and 34 mM citrate and buffered to pH 7 to ensure bacterial
adherence to the microplate. Seeding solutions were then made in this modified LB
medium to reach an OD600 of 0.1. A 100 μL amount of the seeding solutions was added
to each well of the 96 well microplate. The plates were covered and incubated at room
temperature under static conditions for 1 day.
A 2 % v/v emulsion stock solution made by diluting the generated capsules into LB
medium. The stock solution was then diluted to the desired level and incubated with the
biofilms for 3 hrs. Biofilms were washed with phosphate buffer saline (PBS) three times
and viability was determined using an Alamar Blue assay. 52 Modified LB medium
without bacteria was used as a negative control.
6.4.11. Biofilm-3T3 Fibroblast Cell Co-culture
Co-culture was performed as previously described.50 Briefly, a total of 20,000 NIH 3T3
(ATCC CRL-1658) cells were cultured in Dulbecco’s modified Eagle medium (DMEM;
ATCC 30-2002) with 10 % bovine calf serum and 1% antibiotics at 37 °C in a humidified
atmosphere of 5 % CO2. Cells were kept for 24 h to reach a confluent monolayer.
Bacteria were inoculated and harvested as described above, and seeding solutions were
made in buffered DMEM supplemented with glucose to reach an OD600 of 0.1. Old
medium was removed from 3T3 cells followed by addition of 100 μL of seeding solution.
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The co-cultures were then stored in a box with damp paper towels at 37 °C overnight
without shaking.
Testing solutions at different concentrations were made by diluting capsules into DMEM
prior to use. Media was removed from co-culture, replaced with testing solutions, and
incubated for 3 hrs at 37 °C. Co-cultures were then analyzed using a LDH cytotoxicity
assay to determine mammalian cell viability according the manufacturer’s instructions.53
To determine bacteria viability in biofilms, the testing solutions were removed and cocultures were washed with PBS. Fresh PBS was then added to disperse remaining
bacteria from biofilms in co-culture by sonication for 20 minutes and mixing with pipette.
The solutions containing dispersed bacteria were then plated onto agar plates and colony
forming units were counted after incubation at 37 °C overnight.
6.4.12. Calculation of Cinnamaldehyde to Amine Ratio
Diameter of SiO2 NP = 152 nm
Total number of NPs in solution:

𝑁𝑁𝑃 =

𝑁𝑁𝑃 =

𝑀𝑎𝑠𝑠 𝑜𝑓 𝑁𝑃𝑠 𝑖𝑛 𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛
⁄𝐷𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝑠𝑖𝑙𝑖𝑐𝑎 𝑁𝑃𝑠
𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑖𝑛𝑑𝑖𝑣𝑖𝑑𝑢𝑎𝑙 𝑁𝑃
(0.0144 𝑔)
⁄
(1.96

𝑔
)
𝑐𝑚−3
−15
−3
1.84×10
𝑐𝑚

𝑁𝑁𝑃 = 4.00 × 1012
Moles of amine in solution:
𝑀𝑜𝑙𝑒𝑠 𝑜𝑓 𝑁𝐻2 =

𝑀𝑜𝑙𝑒𝑠 𝑜𝑓 𝑁𝐻2 =

𝑁𝑁𝑃 ×𝑆𝑢𝑟𝑓𝑎𝑐𝑒 𝑎𝑟𝑒𝑎 𝑜𝑓 𝑖𝑛𝑑𝑖𝑣𝑖𝑑𝑢𝑎𝑙 𝑁𝑃×# 𝑜𝑓 𝑎𝑚𝑖𝑛𝑒 𝑔𝑟𝑜𝑢𝑝𝑠 𝑝𝑒𝑟 𝑛𝑚2
6.02×1023

𝑎𝑚𝑖𝑛𝑒 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠
𝑚𝑜𝑙

𝑎𝑚𝑖𝑛𝑒 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠
)
𝑛𝑚2
𝑎𝑚𝑖𝑛𝑒 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠
23
(6.02×10
)
𝑚𝑜𝑙

(4.00×1012 )×(72600 𝑛𝑚2 )×(4.0
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𝑀𝑜𝑙𝑒𝑠 𝑜𝑓 𝑁𝐻2 = 1.9 × 10−6 𝑚𝑜𝑙𝑒𝑠
Moles of cinnamaldehyde (CA) in solution:
𝑀𝑜𝑙𝑒𝑠 𝑜𝑓 𝐶𝐴 =

𝑀𝑜𝑙𝑒𝑠 𝑜𝑓 𝐶𝐴 =

𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑐𝑖𝑛𝑛𝑎𝑚𝑎𝑙𝑑𝑒ℎ𝑦𝑑𝑒 𝑖𝑛 𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛×𝐷𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝑐𝑖𝑛𝑛𝑎𝑚𝑎𝑙𝑑𝑒ℎ𝑦𝑑𝑒
𝑀𝑜𝑙𝑎𝑟 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑐𝑖𝑛𝑛𝑎𝑚𝑎𝑙𝑑𝑒ℎ𝑦𝑑𝑒
(0.0150 𝑚𝐿)×(1.05
132.16

𝑔
𝑚𝑜𝑙

𝑔
)
𝑚𝐿

𝑀𝑜𝑙𝑒𝑠 𝑜𝑓 𝐶𝐴 = 1.20 × 10−4 𝑚𝑜𝑙𝑒𝑠
Ratio of CA to NH2:
62
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